50
5101:3-9-12 Appendix AMEND Page 1 of 50 DRUG CLASS DRUG NAME CO-PAYMENT COVERED FOR DUAL ELIGIBLE A1A-DIGITALIS GLYCOSIDES DIGOXIN 0.05MG/ML PED ELIXIR 0 N DIGOXIN 0.125MG, 0.25MG 0 N LANOXIN 0.05MG/ML PED ELIXIR 2 N LANOXIN 0.125MG, 0.25MG 2 N A1B-XANTHINES AMINOPHYLLINE 100MG, 200MG TAB 0 N CAFFEINE CITRATE ORAL SOLN 20MG/ML 0 N DYLIX 100MG/15ML 2 N ELIXOPHYLLIN ELIXIR 80MG/15ML 2 N THEO-24 100MG, 200MG, 300MG, 400MG 2 N THEOPHYLLINE LIQUID 80MG/15ML 0 N THEOPHYLLINE SR TAB 100MG, 200MG, 300MG, 400MG, 450MG, 600MG 0 N A1D-GENERAL BRONCHODILATOR AGENTS ATROVENT HFA 2 N DIFIL-G 400 400-200MG 2 N IPRATROPIUM 0.2MG/ML 0 N SPIRIVA INHALER 18MCG 2 N A2A-ANTIARRHYTHMICS AMIODARONE 200MG 0 N DISOPYRAMIDE CR 150MG 0 N DISOPYRAMIDE PHOSPHATE 100MG, 150MG 0 N FLECAINIDE ACETATE 50MG, 100MG, 150MG 0 N MEXILITENE HCL 150MG, 200MG, 250MG 0 N NORPACE CR 100MG, 150MG 2 N PACERONE 200MG 0 N PROPAFENONE 150MG, 225MG, 300MG 0 N PROPAFENONE ER 225MG, 325MG, 425MG 0 N QUINIDINE GLUCONATE 324MG 0 N QUINIDINE SULFATE 200MG, 300MG 0 N QUINIDINE SULFATE SR 300MG 0 N TIKOSYN 0.125MG, 0.25MG, 0.5MG 2 N A2C-ANTI-ANGINAL AND ANTI-ISCHEMIC AGENTS, NON-HEMODYNAMIC RANEXA 500MG, 1000MG 2 N A4A-ANTIHYPERTENSIVES, VASODILATORS HYDRALAZINE HCL 10MG, 25MG, 50MG, 100MG 0 N MINOXIDIL 2.5MG, 10MG 0 N A4B-ANTIHYPERTENSIVES, SYMPATHOLYTIC CATAPRES-TTS 0.1MG, 0.2MG, 0.3MG 0 N CLONIDINE HCL 0.1MG, 0.2MG, 0.3MG 0 N CLORPRES 0.2/15 2 N GUANABENZ 4MG, 8MG 0 N GUANFACINE 1MG, 2MG 0 N METHYLDOPA 250MG, 500MG 0 N METHYLDOPA/HCTZ 250/15, 250/25 0 N Effective January 1, 2013 November 1, 2013 ACTION: Original DATE: 08/07/2013 1:34 PM AMENDED Appendix 5101:3-9-12 APPENDIX p(107517) pa(188865) d(438141) ra(348072) print date: 08/07/2013 9:08 PM

ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 1 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

A1A-DIGITALIS GLYCOSIDESDIGOXIN 0.05MG/ML PED ELIXIR 0 NDIGOXIN 0.125MG, 0.25MG 0 NLANOXIN 0.05MG/ML PED ELIXIR 2 NLANOXIN 0.125MG, 0.25MG 2 N

A1B-XANTHINESAMINOPHYLLINE 100MG, 200MG TAB 0 NCAFFEINE CITRATE ORAL SOLN 20MG/ML 0 NDYLIX 100MG/15ML 2 NELIXOPHYLLIN ELIXIR 80MG/15ML 2 NTHEO-24 100MG, 200MG, 300MG, 400MG 2 NTHEOPHYLLINE LIQUID 80MG/15ML 0 NTHEOPHYLLINE SR TAB 100MG, 200MG, 300MG, 400MG, 450MG, 600MG 0 N

A1D-GENERAL BRONCHODILATOR AGENTS ATROVENT HFA 2 NDIFIL-G 400 400-200MG 2 NIPRATROPIUM 0.2MG/ML 0 NSPIRIVA INHALER 18MCG 2 N

A2A-ANTIARRHYTHMICSAMIODARONE 200MG 0 NDISOPYRAMIDE CR 150MG 0 NDISOPYRAMIDE PHOSPHATE 100MG, 150MG 0 NFLECAINIDE ACETATE 50MG, 100MG, 150MG 0 NMEXILITENE HCL 150MG, 200MG, 250MG 0 NNORPACE CR 100MG, 150MG 2 NPACERONE 200MG 0 NPROPAFENONE 150MG, 225MG, 300MG 0 NPROPAFENONE ER 225MG, 325MG, 425MG 0 NQUINIDINE GLUCONATE 324MG 0 NQUINIDINE SULFATE 200MG, 300MG 0 NQUINIDINE SULFATE SR 300MG 0 NTIKOSYN 0.125MG, 0.25MG, 0.5MG 2 N

A2C-ANTI-ANGINAL AND ANTI-ISCHEMIC AGENTS, NON-HEMODYNAMICRANEXA 500MG, 1000MG 2 N

A4A-ANTIHYPERTENSIVES, VASODILATORSHYDRALAZINE HCL 10MG, 25MG, 50MG, 100MG 0 NMINOXIDIL 2.5MG, 10MG 0 N

A4B-ANTIHYPERTENSIVES, SYMPATHOLYTICCATAPRES-TTS 0.1MG, 0.2MG, 0.3MG 0 NCLONIDINE HCL 0.1MG, 0.2MG, 0.3MG 0 NCLORPRES 0.2/15 2 NGUANABENZ 4MG, 8MG 0 NGUANFACINE 1MG, 2MG 0 NMETHYLDOPA 250MG, 500MG 0 NMETHYLDOPA/HCTZ 250/15, 250/25 0 N

Effective January 1, 2013 November 1, 2013

ACTION: Original DATE: 08/07/2013 1:34 PMAMENDEDAppendix

5101:3-9-12

APPENDIX p(107517) pa(188865) d(438141) ra(348072) print date: 08/07/2013 9:08 PM

Page 2: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 2 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

A4C-ANTIHYPERTENSIVES, GANGLIONIC BLOCKERSINVERSINE 2.5MG 2 NVECAMYL 2.5 MG TABLET 2 N

A4D-ANTIHYPERTENSIVES, ACE INHIBITORSBENAZEPRIL 5MG, 10MG, 20MG, 40MG 0 NCAPTOPRIL 12.5MG, 25MG, 50MG, 100MG 0 NENALAPRIL 2.5MG, 5MG, 10MG, 20MG 0 NFOSINOPRIL 10MG, 20MG, 40MG 0 NLISINOPRIL 2.5MG, 5MG, 10MG, 20MG, 30MG, 40MG 0 NMOEXIPRIL 7.5MG, 15MG 0 NPERINDOPRIL 2MG, 4MG, 8MG 0 NQUINAPRIL 5MG, 10MG, 20MG, 40MG 0 NRAMIPRIL 1.25MG, 2.5MG, 5MG, 10MG 0 NTRANDOLAPRIL 1MG, 2MG, 4MG 0 N

A4F-ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST AVAPRO 75MG, 150MG, 300MG 0 NIRBESARTAN 75MG, 150MG, 300MG 0 NLOSARTAN 25MG, 50MG, 100MG 0 N

A4I-ANGIOTENSIN RECEPTOR ANTAG./THIAZIDE DIURETIC COMB AVALIDE 150-12.5MG, 150-25MG, 300-25MG 0 NDIOVAN HCT 80-12.5MG, 160-12.5MG, 160-25MG, 320-12.5MG, 320-25MG 0 NIRBESARTAN/HCTZ 150-12.5MG, 150-25MG, 300-25MG 0 NLOSARTAN/HCTZ 50-12.5MG, 100-12.5MG, 100-25MG 0 N

A4J-ACE INHIBITOR/THIAZIDE & THIAZIDE-LIKE DIURETIC BENAZEPRIL/HCTZ 5-6.25MG, 10-12.5MG, 20-12.5MG, 20-25MG 0 NCAPTOPRIL/HCTZ 25/15, 25/25, 50/15, 50/25 0 NENALAPRIL/HCTZ 5/12.5, 10/25 0 NFOSINOPRIL/HCTZ 10-12.5MG, 20-12.5MG 0 NLISINOPRIL/HCTZ 10/12.5, 20/12.5, 20/25 0 NMOEXIPRIL/HCTZ 7.5-12.5, 15-12.5, 15-25 0 NQUINAPRIL/HCTZ 10-12.5, 20-12.5, 20-25 0 N

A4K-ACE INHIBITOR/CALCIUM CHANNEL BLOCKER COMBINATION LOTREL 10/2.5, 10/5, 10/20, 20/5 0 NLOTREL 40/5, 40/10 0 NTARKA 2/180, 1/240, 2/240, 4/240 0 N

A4Y-ANTIHYPERTENSIVES, MISCELLANEOUSDEMSER 250MG 2 N

A7B-CORONARY VASODILATORSDILATRATE SR 40MG 2 NISORDIL 40MG 2 NISOSORBIDE DINITRATE ORAL 5MG, 10MG, 20MG, 30MG 0 NISOSORBIDE DINITRATE SL 2.5MG, 5MG 0 NISOSORBIDE DINITRATE SR 40MG 0 NISOSORBIDE MONONITRATE 10MG, 20MG, 30MG, 60MG, 120MG 0 NMINITRAN 0.1MG/HR, 0.2MG/HR, 0.4MG/HR, 0.6MG/HR 2 NNITROBID OINT 2% 2 N

Effective January 1, 2013 November 1, 2013

Page 3: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 3 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

NITRO-DUR 0.1MG/HR, 0.2MG/HR, 0.3MG/HR, 0.4MG/HR, 0.6MG/HR, 0.8MG/HR 2 NNITROGLYCERIN PATCHES 0.1MG/HR, 0.2MG/HR, 0.4MG/HR, 0.6MG/HR 0 NNITROGLYCERIN SL 0.3, 0.4, 0.6 0 NNITROLINGUAL SPRAY 0.4MG/DOSE 2 NNITROQUICK 0.3MG, 0.4MG, 0.6MG 0 NNITROSTAT 0.3MG, 0.4MG, 0.6MG 2 N

A7C-PERIPHERAL VASODILATORSPAPAVERINE HCL 150MG 0 N

A9A-CALCIUM CHANNEL BLOCKERSAMLODIPINE 2.5MG, 5MG, 10MG 0 NDILTIAZEM 30MG, 60MG, 90MG, 120MG 0 NDILTIAZEM ER 24 HOUR 120MG, 180MG, 240MG, 300MG, 360MG, 420MG 0 NDILTIAZEM SR 12 HOUR 60MG, 90MG, 120MG 0 NFELODIPINE ER 2.5MG, 5MG, 10MG 0 NNICARDIPINE HCL 20MG, 30MG 0 NNIFEDIPINE 10MG, 20MG 0 NNIPEDIPINE ER 30MG, 60MG, 90MG 0 NTAZTIA XT 120MG, 180MG, 240MG, 300MG, 360MG 0 NVERAPAMIL HCL 40MG, 80MG, 120MG 0 NVERAPAMIL SR 120MG, 180MG, 240MG, 360MG 0 N

B0A-GENERAL INHALATION AGENTSSODIUM CHLORIDE FOR INHALATION 0.9%, 3%, 7%, 10% 0 N

B0B-CYSTIC FIB.TRANSMEMB CONDUCT.REG.(CFTR)POTENTIATOR KALYDECO 150MG 2 N

B3A-MUCOLYTICSACETYLCYSTEINE SOLN 10%, 20% 0 NPULMOZYME 2.5MG 2 N

B3J-EXPECTORANTS (guaifenesin may be covered for dual eligible)GUAIFENESIN 200MG, 400MG, 600MG 0 YGUAIFENESIN SYRUP 100MG/5ML, 200MG/5ML 0 YMUCINEX TABLET 600MG, 1200MG 2 Y

B3N-DECONGESTANT-ANALGESIC-EXPECTORANT COMBINATION MUCINEX COLD & SINUS LIQUID 10-650/20 2 NMUCINEX FAST-MAX COLD-SINUS 200-5-325 2 N

B3O-1ST GEN ANTIHISTAMINE-DECONGESTANT-ANALGESIC COMB DIPHENHYDRAMINE/PHENYLEPHRINE/ACETAMINOPHEN 25-650/30, 25-5-325MG 0 NPHENYLEPHRINE/ACETAMINOPHN/CP 5-325-2MG 0 NROBITUSSIN COUGH-COLD-FEVER 2 N

DELSYM MULTI-SYMPTOM 5-325/15ML 2 YDEXTROMETHOR/PHENYLEPHRINE/APAP/CHLORPHENIR 5-2.5-160, 10-5-325-2 0 YDEXTROMETHOR/PHENYLEPHRINE/APAP/DOXYLAMINE 5-325/15, 15-500/15 0 Y

B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

Effective January 1, 2013 November 1, 2013

Page 4: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 4 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

BROMPHENIRAMINE/PSEUDOEPHEDRINE/CODEINE 1.3-10-6.3MG 0 YCHLORPHENIRAMINE/PE/CODEINE 2-5-10MG/5 0 YM-END PE 3.3-6.3/5ML 2 YPRO-RED AC 8.33-5-9/5ML 2 YPROMETHAZINE VC CODEINE SYRUP 0 YPSEUDOEPHEDRINE/CHLORPHENIRAMINE/CODEINE 30-10-2/5ML 0 YPSEUDOEPHEDRINE HCL/CODEINE/GUAIFENISEN 30-9-200/5 0 Y

DEXTROMETHORPHAN/PHENYLEPHRIN/BROMPHENIRAMINE 5-2.5-1/5, 2-5-10MG/5 0 YDEXTROMETHORPHAN/PHENYLEPHRINE/CHLORPHENIRAMINE 3-2-1MG/ML, 3-1.5-1/ML, 3-3.5-1/ML, 15-10-2/5ML, 15-6-2/5ML, 15-5-2/5ML, 15-10-4/5ML 0 YDEXTROMETHORPHAN/PSEUDOEPHRINE/BROMPHENIRAMINE 4-15-1/1ML, 5-12-1MG/MML, 5-15-1MG/5, 15-45-4/5, 10-30-2/5 0 YDEXTROMETHORPHAN/PSEUDOEPHRINE/CHLORPHENIRAMINE 5-15-1/5 0 YM-END DM 15-15-2/5ML 2 YPHENYLEPH/PYRIL/DM 5-8.33-10/5ML 0 YRESCON DM 10-30-2/5 2 Y

GUAIFENISEN/DEXTROMETHORPHAN/PHENYLEPHRINE/CHLORPHENERIMAINE 15-10-2/5 0 Y

GUAIFENESIN/DEXTROMETHORPHAN 100-5MG/5, 100-10/5, 200-10/5, 200-10/15, 300-20/5, 400-20MG TAB, 600-30MG, 1200-60MG 0 YMUCINEX DM TABLET 600-30MG, 1200-60MG 2 YROBITUSSIN DM 200-10MG/5ML 2 Y

B3X-1ST GEN ANTIHIST-DECONGEST-ANTICHOLINERGIC COMB CHLORPHENIRAMINE/PHENYLEPHRINE/METHSCOP 2-10-0.75/5 0 N

DEXTROMETHORPHAN/ACETAMINOPHEN 30-1000/30, 5-160/5 0 Y

HYDROCODONE/HOMATRO 5/1.5 TAB, SYRUP 0 Y

COTAB AX 4-20MG 2 YPRO-CLEAR AC 9-8.33MG/5ML 2 YPROMETHAZINE CODEINE SYRUP 10-6.25/5ML 0 Y

B4C-NARCOTIC ANTITUSSIVE-ANTICHOLINERGIC COMB. (cough suppressants may be covered for dual eligible)

B4D-NARCOTIC ANTITUSSIVE-1ST GENERATION ANTIHISTAMINE (cough suppressants may be covered for dual eligible)

B4A-NON-NARCOTIC ANTITUSSIVE-ANALGESIC COMBINATIONS (cough suppressants may be covered for dual eligible)

B3Q-NARCOTIC ANTITUSS-1ST GEN. ANTIHISTAMINE-DECONGEST (cough suppressants may be covered for dual eligible)

B3R-NON-NARC ANTITUSS-1ST GEN. ANTIHISTAMINE-DECONGEST (cough suppressants may be covered for dual eligible)

B3S-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECONGEST-EXPECT (cough suppressants may be covered for dual eligible)

B3T-NON-NARCOTIC ANTITUSSIVE AND EXPECTORANT COMB (cough suppressants may be covered for dual eligible)

Effective January 1, 2013 November 1, 2013

Page 5: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 5 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

CAPRON DM 7.5-7.5/5ML 2 YDEXTROMETHORPHAN/CHLORPHENIRAMINE 7.5-1MG/5ML 0 YDEXTROMETHORPHAN HB/DOXYLAMINE 15-6.25/15 0 YPROMETHAZINE DM SYRUP 15-6.25/5 0 Y

DEXTROMETHROPHAN/ACETAMINOPHEN/DOXYLAMINE 30-12.5/30 0 YDEXTROMETHORPHAN/ACETAMINOPHEN/CHLORPHENIRAMINE 5-160-1/5 N Y

PSEUDOEPHEDRINE HCL/CODEINE 30-10MG/5 0 Y

DEXTROMETHORPHAN/PHENYLEPHRINE 5-2.5MG/5 0 Y

DEXTROMETHORPHAN/PE/ACETAMINOPHEN 5-325MG/15, 10-5-325 0 Y

CHILD'S MUCINEX COLD-FEVER 5-325/10 2 YMUCINEX COLD-FLU-SORETHROAT 10-650/20 2 YPHENYLEPHRINE/DM/ACETAMINOP/GG 5-325-200, 5-325MG/15 N Y

GUAIFENESIN/PSEUDOEPHEDRINE/CODEINE 100-30-10/5, 200-30-9/5 0 Y

CAPMIST DM 400-30-30, 400-15-60 2 YCHILD MUCINEX MULTI-SYMPTOM 5-2.5MG/5 2 YGUAIFENISEN/DEXTROMETHORPHAN/PHENYLEPHRINE 100-10-5/5ML 0 YGUAIFENESIN/DEXTROMETHORPHAN/PSEUDOEPHEDRINE 200-15-30/5 0 YTUSNEL PEDIATRIC LIQUID 50-5-15/5ML 2 Y

GUAIFENESIN/CODEINE CAPS 200-9 0 YGUAIFENESIN W/CODEINE SYRUP 100-6.3MG/5, 100-10MG/5, 200-10MG/5 0 Y

B4T-DECONGEST-ANALGESIC,NON-SALICYLATE COMB. PHENYLEPHRINE/ACETAMINOPHEN 5MG-325MG 0 N

B4W-DECONGESTANT-EXPECTORANT COMBINATIONSGUAIFENESIN/PHENYLEPHRINE 400-10MG 0 NGUAIFENESIN/PSEUDOEPHEDRINE HCL 400MG-40MG, 400MG-60MG 0 NMUCINEX COLD 100-2.5/5ML 2 N

B4E-NON-NARC ANTITUSSIVE-1ST GEN ANTIHISTAMINE COMB (cough suppressants may be covered for dual eligible)

B4G-NON-NARC ANTITUSS-1ST GEN ANTIHIST-ANALGESIC COMB (cough suppressants may be covered for dual eligible)

B4K-NARCOTIC ANTITUSSIVE-DECONGESTANT COMBINATIONS (cough suppressants may be covered for dual eligible)

B4L-NON-NARCOTIC ANTITUSSIVE-DECONGESTANT COMBINATIONS (cough suppressants may be covered for dual eligible)

B4M-NON-NARCOTIC ANTITUSSIVE-DECONGESTANT-ANALGESIC CB (cough suppressants may be covered for dual eligible)

B4P-NON-NARC ANTITUSS-DECONGESTANT-ANALGESIC-EXPECT CB (cough suppressants may be covered for dual eligible)

B4Q-NARCOTIC ANTITUSS-DECONGESTANT-EXPECTORANT COMB (cough suppressants may be covered for dual eligible)

B4R-NON-NARCOTIC ANTITUSS-DECONGESTANT-EXPECTORANT CMB (cough suppressants may be covered for dual eligible)

B4S-NARCOTIC ANTITUSSIVE-EXPECTORANT COMBINATION (cough suppressants may be covered for dual eligible)

Effective January 1, 2013 November 1, 2013

Page 6: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 6 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

MUCINEX D 600-60MG, 1200-120MG 2 NRESCON GG 100-5/5ML 2 NRESPAIRE-30 150MG-30MG 2 N

C0B-WATERSTERILE WATER FOR INJECTION 0 N

C0D-ANTI-ALCOHOLIC PREPARATIONSANTABUSE 250MG, 500MG 2 NCAMPRAL 333MG 2 NDISULFIRAM 250MG 0 NVIVITROL 380MG 0 N

C1A-ELECTROLYTE DEPLETERSCALCIUM ACETATE 667MG 0 NCALPHRON 667MG 0 NELIPHOS 667MG 0 NKAYEXALATE POWDER 2 NKIONEX PDR 0 NPHOSLO 667MG 2 NSODIUM POLYSTYRENE SULFONATE 15GM/60ML 0 N

C1B-SODIUM/SALINE PREPARATIONS NORMAL SALINE WASH 0 N

C1D POTASSIUM REPLACEMENTEFFER-K TABLETS 10MEQ, 20MEQ 2 NKLOR-CON 25 PACKETS 2 NKLOR-CON M15 2 NPOTASSIUM CHLORIDE 8MEQ, 10MEQ, 20MEQ 0 NPOTASSIUM CHLORIDE EFF TABS 25MEQ 0 NPOTASSIUM CHLORIDE ORAL LIQ 10%, 20% 0 NPOTASSIUM CHLORIDE PACKETS 20MEQ, 25MEQ 0 N

C1F-CALCIUM REPLACEMENT (may be covered for dual eligible)CALCIUM CITRATE-VITAMIN D 315-250 0 YCALCIUM CARBONATE 1.25 GM 0 YCALCIUM CARBONATE 10GR 0 YCALCIUM CARBONATE/VITAMIN D 153-100, 600-200, 600-400, 600-500 0 YCALCIUM CITRATE 950MG 0 YCALCIUM GLUBIONATE 1.8GM/5ML 0 YCALCIUM GLUCONATE 10GR 0 YCALCIUM LACTATE 10GR 0 YOYSTER SHELL CALC W/D 250MG/125U, 500MG/200U, 500MG/400U 0 YOYSTER SHELL CALCIUM 500MG 0 Y

C1H-MAGNESIUM SALTS REPLACEMENT (may be covered for dual eligible)MAG DELAY 64MG 0 YMAGNESIUM CARBONATE 64MG/5ML 0 YMAGNESIUM GLUCONATE 500MG 0 YMAGNESIUM OXIDE 400MG 0 YMAGTAB SR 84MG 2 YSLOW MAG 71.5MG 2 Y

Effective January 1, 2013 November 1, 2013

Page 7: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 7 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

C1P-PHOSPHATE REPLACEMENT (may be covered for dual eligible)PHOS-NAK 2 Y

C1W-ELECTROLYTE MAINTENANCEORAL ELECTROLYTES 0 YPEDIALYTE SOLUTION 2 Y

C3B-IRON REPLACEMENT (may be covered for dual eligible)BIFERA 28MG 2 YCORVITE 150 2 YFEFUM/C/B12/IF/FA 0.5MG 0 YFERRALET 90 DUAL-IRON 90-1-50 MG 2 YFERRAPLUS 90-1-50MG 2 YFERROGELS FORTE 460/60MG 0 YFERROUS FUM/C/B-12 0 YFERROUS FUMARATE/FOLIC ACID 106 MG-1MG 0 YFERROUS FUMARATE/FA/MULTIVITAMIN/MINERAL COMB 10-MG-1MG 0 YFERROUS GLUCONATE 236MG 0 YFERROUS GLUCONATE EC 5GR 0 YFERROUS SULFATE 140MG, 5GR, SLOW RELEASE 160MG 0 YFERROUS SULFATE 220MG/5ML, 15MG/1ML 0 YFERROUS/FA/B&C 0 YHEMATOGEN 0 YHEMATOGEN FA 200-250MG 0 YHEMATOGEN FORTE 460-60MG 0 YIRON AG/C/B12/CA/SUC.ACID/STOM 70-150-10 0 YIRON,CARBONYL/FOLIC ACID 82MG-0.8MG 0 YIRON FUM & AG/C/B12/FA/CA/SUCC 151-60-1 0 YMULTIVITS,THERAP W-FE,HEMATIN 27-0.8MG 0 YMYKIDZ IRON 10 SUSPENSION 15MG/1.5ML 0 YNEPHRON FA 2 YPOLYSACCARIDE IRON 150 FORTE 0 YPOLYSACCARIDE IRON 150MG 0 YPOLYSACCARIDE IRON 150 PLUS 0 YPRO FE 180MG 2 YSE-TAN PLUS 106MG-1MG 0 YSTRESS FORMULA + IRON 0 Y

C3C-ZINC REPLACEMENT (may be covered for dual eligible)ZINC 50MG 2 YZINC SULFATE 220MG 2 Y

C3H-IODINE CONTAINING AGENTS (may be covered for dual eligible)POTASSIUM IODIDE 1GM/ML 0 Y

C4G-INSULINSHUMALOG 100U/ML 2 NHUMALOG MIX 50/50, 75/25 2 NHUMULIN 70/30 2 NHUMULIN N 2 NHUMULIN R 100U/ML, HUMULIN R-500 500U/ML 2 N

Effective January 1, 2013 November 1, 2013

Page 8: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 8 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

LANTUS 100U/ML 2 NNOVOLIN 70/30 2 NNOVOLIN N 2 NNOVOLIN R 2 NNOVOLOG 2 NNOVOLOG MIX 70/30 2 NRELION 70/30 2 NRELION N 2 NRELION R 2 N

C4K-HYPOGLYCEMICS, INSULIN-RELEASE STIMULANT TYPE CHLORPROPAMIDE 100MG, 250MG 0 NGLIMEPIRIDE 1MG, 2MG, 4MG 0 NGLIPIZIDE 5MG, 10MG 0 NGLIPIZIDE-METFORMIN 2.5-500, 5-500 0 NGLIPIZIDE ER 2.5MG, 5MG, 10MG 0 NGLYBURIDE 1.25MG, 2.5MG, 5MG 0 NGLYBURIDE MICRONIZED 1.5MG, 3MG, 6MG 0 NSTARLIX 60MG, 120MG 0 NTOLAZAMIDE 250MG, 500MG 0 NTOLBUTAMIDE 500MG 0 N

C4L-HYPOGLYCEMICS, BIGUANIDE TYPE (NON-SULFONYLUREAS) METFORMIN 500MG, 850MG, 1000MG 0 NMETFORMIN HCL ER 500MG, 750MG 0 N

C4M-HYPOGLYCEM, ALPHA-GLUCOSIDASE INHIB TYPE (N-S)ACARBOSE 25MG, 50MG, 100MG 0 NGLYSET 25MG,50MG,100MG 2 N

C4N-HYPOGLYCEMICS, INSULIN-RESPONSE ENHANCER (N-S)ACTOS 15MG, 30MG, 45MG 0 NPIOGLITAZONE 15MG, 30MG, 45MG 0 N

C4S-HYPOGLY, INSULIN-REL STIM. & BIGUANIDE (N-S) COMB. GLYBURIDE-METFORMIN 1.25-250, 2.5-500, 5-500 0 N

C4T-ANTIHYPERGLYCEMIC,THIAZOLIDINEDIONE & BIGUANIDE ACTOPLUS MET 15-500MG, 15-850MG 0 N

C5B-PROTEIN REPLACEMENT (may be covered for dual eligible)ARGININE 500MG 0 Y

C5F-DIETARY SUPPLEMENTS, MISC (may be covered for dual eligible)CO ENZYME Q10 30MG, 100MG 0 YCYTO-Q MAX 100 MG/ML LIQUID 2 YLIQ10 50MG/5ML 0 YQ-GEL MEGA 100MG 0 Y

C5O-SOLNS MISCELLANEOUSDILUENT 2 N

C5U-NUTRITIONAL THERAPY, MED COND SPECIAL FORMULATION (may be covered for dual eligible)SLOESTEROL POWDER 2 Y

Effective January 1, 2013 November 1, 2013

Page 9: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 9 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

C6B-VITAMIN B PREPARATIONS (may be covered for dual eligible)CEREFOLIN 1-6-50-5MG 2 YCEREFOLIN NAC 2 YDIALYVITE 3000 2 YDIALYVITE 5000 0 YDIALYVITE WITH ZINC TABLET 1-100MG 0 YFOLBEE 1-2.5-25MG 2 YFOLBEE PLUS 2 YFOLBIC 2-2.5-25MG 2 YFOLGARD RX 1-2.2-25 2 YFOLIC ACID/VITAMIN B COMP W-C 0 YFOLTX 2-2.5-25 2 YMETANX 2-2.8-25MG 2 YNEPHPLEX RX 2 YNEPHROCAPS QT 1MG-1750 0 YNEPHRONEX 1MG 2 YNEPHRO-VITE RX 2 YRENAL CAPS 1MG 2 YRENA-VITE 0 YRENA-VITE RX 0 YRENO CAPS 1MG 2 Y

C6C-VITAMIN C PREPARATIONS VITAMIN C 500MG 0 Y

C6D-VITAMIN D PREPARATIONS (may be covered for dual eligible)CALCIFEROL LIQ 8,000U/ML 2 YCALCITRIOL 0.25MCG, 0.5MCG, 1MCG/ML 0 YD-VI-SOL 400/ML 2 YDRISDOL 8000 IU/ML 2 YERGOCALCIFEROL 8000 IU/ML 0 YROCALTROL 0.25MCG, 0.5MCG 2 YROCALTROL 1MCG/ML 2 YVITAL-D RX 1750-60-1 0 YVITAMIN D2 50,000U 0 YVITAMIN D3 1000U, 2000U, 5000U, 10000U 0 Y

C6E-VITAMIN E PREPARATIONS (may be covered for dual eligible)AQUASOL E 50 UNIT/ML DROPS 2 YAQUA-E LIQUID 30-2MG/ML 2 Y

C6F-PRENATAL VITAMINS (family planning)CAVAN ONE OMEGA 27-1-330MG 0 NCAVAN-ALPHA KIT 27-1-300MG 0 NCAVAN-EC SOD DHA VITAMINS 30-1-440 0 NCAVAN-FOLATE DHA COMBO PACK 65-1-250 0 NCAVAN-FOLATE OB TABLET 65-1 0 NCAVAN-HEME OB TABLET 22-6-1 0 NCAVAN-HEME OMEGA COMBO PACK 22-6-1-200 0 NCITRANATAL 90 DHA 90-1-300MG 0 N

Effective January 1, 2013 November 1, 2013

Page 10: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 10 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

CITRANATAL ASSURE 35-1-50MG 0 NCITRANATAL B-CALM 20-1-25MG 0 NCITRANATAL DHA 27-1-50MG 0 NCITRANATAL HARMONY 27-1-50MG 0 NCITRANATAL RX 27-1-50 0 NCOMPLETE NATAL DHA 29-1-250MG 0 NCOMPLETENATE 29MG-1MG 0 NCOMPLETE-RF PRENATAL 90-1-50MG 0 NCO-NATAL FA 0 NCONCEPT DHA 35-1-200MG 0 NCONCEPT OB 85MG-1MG 0 NCORENATE-DHA 35-1-50 0 NDUET DHA COMPLETE 27-1-300MG, 27-1-430MG, BALANCED 27-1-430 0 NED CYTE F TABLET 106-50-1 0 NEDGE OB 29MG-1MG 0 NELITE OB 400, DHA SOFTGEL 28-1.25 0 NEZFE FORTE 155-1 0 NFEMECAL OB 22-6-1MG, FEMECAL OB PLUS DHA 22-6-1-200 0 NFOLBECAL TABLET 200-12-1 0 NFOLCAL DHA 30-1.24-55, 27-1.25-55 0 NFOLCAPS CARE ONE 27-1-50MG 0 NFOLCAPS OMEGA-3 27-1-330MG 0 NFOLINATAL PLUS B 200-12-1 0 NFOLIVANE-EC CALCIUM DHA COM 27-1-250MG 0 NFOLIVANE-OB CAPSULE 85 MG-1 MG 0 NFOLIVANE-PRX DHA NF CAPSULE 30-1.24-55 0 NFOLTABS 27-1-50MG 0 NFOLTABS 90 PLUS DHA 0 NGENERIC PRENATALS 0 NGESTICARE DHA 0 NHIP PRENATAL 22-6-1 0 NINATAL ADVANCE 90-1MG 0 NINATAL GT 90-1MG 0 NINATAL ULTRA 90-1MG 0 NINFANATE BALANCE 29-1-50 DHA 28-1-250 0 NKOLNATAL DHA 27-1-250MG 0 NLACTOCAL-F TABLET 65-1 0 NMARNATAL-F 0 NMATERNITY VITAMIN 27-1 0 NMISSION PRENATAL, PRENATAL FA, PRENATAL HP 0 NMULTINATAL PLUS 30-1MG, 40-1MG 0 NMULTI-NATE 30 DHA 29-1-400, 29-1-430, DHA EXTRA 29-1-400, 29-1-430 0 NNATAFORT 60-1 0 NNATELLE-EZ 25-0.8 0 NNATELLE ONE CAPSULE 28-1-250 0 NNATELLE PLUS COMBO PACK 26-1-200MG 0 N

Effective January 1, 2013 November 1, 2013

Page 11: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 11 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

NAVATAB + DHA 26-1-200MG 0 NNEEVO 29-0.5-1.4 0 NNEEVO DHA 27-1.13 0 NNESTABS ABC PRENATAL COMBO 32-1-120 0 NNEXA SELECT 29-1.25-55 0 NOB COMPLETE 400 35-5-1.2MG, 20-1-100, WITH DHA 30-10-1-200, PREMIER 30-20-1, ONE 40-10-1; PETITE 35-5-1-200 0 NO-CAL PRENATAL 0 NPAIRE OB PLUS DHA 22-6-1-200 0 NPNV-DHA 27-1, PNV-IRON 29-400-1, PNV-SELECT 27-1-300 0 NPNV OB+DHA 27-1-50-250, 27-1-50 0 NPNV-OMEGA 28-1-300 0 NPNV-TOTAL 35-5-1.2 0 NPOLY IRON PN FORTE 60-1MG 0 NPR NATAL 400, 430, 430 EC, 440 EC 0 NPREFERA-OB ONE 22-6-1-200, PREFERA-OB PLUS DHA 22-6-1-200 0 NPRENAFIRST 0 NPRENAPLUS 27MG-1MG 0 NPRENATABS FA 0 NPRENATABS RX 0 NPRENATAL 1 PLUS 1 TABLET 65-1 0 NPRENATAL 19 0 NPRENATAL LOW IRON 27-1MG 0 NPRENATAL MULTIVITAMIN WITH IRON 29MG-1MG 0 NPRENATAL PLUS IRON 27-1 0 NPRENATAL, PRENATAL RX 27-0.5 0 NPRENATAL-U 0 NPRENATE DHA SOFTGEL 27-1-300MG 0 NPRENATE ELITE TABLET 27 MG-1 MG 0 NPRENATE ESSENTIAL 28-1-300MG 0 NPRENEXA 27-1.25-55, PRENEXA PREMIER 27-1.25-55 0 NPREQUE 10 15-0.5-50 0 NPROFE FORTE 155-1 0 NPROVIDA OB CAPSULE 40-1.25 0 NPRUET DHA 29-1-430 0 NRE DUALVIT OB 0 NRE OB + DHA, RE OB 90 + DHA 0 NRE-NATA 29 OB 29MG-1MG 0 NRELNATE DHA 28-1-200 0 NRENATE DHA 0 NROVIN-A DHA 35-1-50-300, ROVIN-NV DHA 27-400-1 0 NSE-CARE 40-1, SE-CARE GESTURE 28-1 0 NSE-NATAL 19 29-1 0 NSE-PLETE DHA 0 NSE-TAN DHA 30-1-310.1 0 NSETONET, SETONET-EC 0 N

Effective January 1, 2013 November 1, 2013

Page 12: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 12 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

STUART PRENATAL, STUART ONE 27-800-200 0 NTARON-BC 20-1-25 0 NTARON EC CALCIUM DHA 28-1-250 0 NTARON-C DHA CAPSULE 35-1-200 0 NTARON-DUO EC 29-1-400 0 NTARON-EC CAL 28-1, TARON PRENATAL 30-1.2-55, TARON A PRENATAL 35-1-50 0 NTARON-PREX PRENATAL DHA 30-1.2-55 0 NTL-ASSURE + DHA 29-1-250 0 NTL CARE DHA 27-1-500, TL SELECT DHA 29-1.25-55 0 NTRICARE PRENATAL DHA ONE 27-1-500MG, COMPLETE 27-1 0 NTRIMESIS RX 200-12-1 0 NTRINATAL GT, ULTRA 90-1-50 0 NTRINATAL RX 1 60MG-1MG 0 NTRINATE 0 NTRIVEEN-DUO DHA 29-1-400 0 NTRIVEEN-ONE 27-1-250MG, TRIVEEN-PRX RNF 26-1.2-55, TRIVEEN-U 106.5-1MG 0 NTRIVEEN-TEN 15-0.5-50 0 NULTIMATECARE COMBO 30-50-1MG, ULTIMATECARE ADVANTAGE 30-1-50 0 NULTIMATECARE ONE 27-1-330MG 0 NVEMAVITE-PRX 2 27-1.25-55 0 NVENATAL-FA 29-1 0 NVINACAL 27-1-50 0 NVINATE AZ 27-1 0 NVINATE AZ EXTRA 0 NVINATE C 30MG-1MG 0 NVINATE CALCIUM 27-1-50MG 0 NVINATE CARE 40-1MG 0 NVINATE GT 0 NVINATE II 29MG-1MG 0 NVINATE M 0 NVINATE ONE 0 NVINATE PN CARE 30-50-1MG 0 NVITAPHIL + DHA 0 NVITAPHIL 25-1MG 0 NVITAFOL-ONE 29-1-200 0 NVITASPIRE 29MG-1MG 0 NVOL-NATE 28-1, VOL-PLUS 27-1, VOL-TAB RX 29-1 0 NZATEAN-CH 27-1-50 0 NZATEAN-PN 27MG-1MG, ZATEAN-PN DHA 27-400-1 0 NZATEAN-PN PLUS 28-1-300MG 0 N

C6G-GERIATRIC VITAMIN PREPARATIONS (may be covered for dual eligible)ELDERCAPS 2 YGERIATRIC VITAMINS (COMPARE TO GEVRABON) 0 YGERI-TONIC 0 YGERIATON 0 Y

Effective January 1, 2013 November 1, 2013

Page 13: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 13 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

C6H-PEDIATRIC VITAMINS (may be covered for dual eligible)CHEWABLES AND LIQUID DROPS GENERICS 0 YCHEWABLES W/FLUORIDE AND LIQUID DROPS W/FLUORIDE 0 YCHEWABLES WITH IRON AND FLUORIDE GENERICS 0 YCHEWABLES WITH IRON AND LIQUID DROPS WITH IRON GENERICS 0 YLIQUID DROPS WITH IRON AND FLUORIDE GENERICS 0 YMYKIDZ IRON FL 10-0.25/2ML 2 Y

C6I-ANTIOXIDANT MULTIVITAMIN COMBINATIONS VIT A/VIT C/VIT E/ZINC/COPPER 0 Y

C6K-VITAMIN K PREPARATIONS (may be covered for dual eligible)MEPHYTON 5MG 2 Y

C6L-VITAMIN B-12 PREPARATIONS (may be covered for dual eligible)CYANOCOBALAMIN INJ 1000MG/ML 0 YFOLCAPS 0.5-2.2-25MG 2 YFOLPLEX 2.2MG 2 Y

C6M-FOLIC ACID PREPARATIONS (may be covered for dual eligible)DIALYVITE 0 YFOLIC ACID 0.8MG, 1MG 0 Y

C6N-NIACIN PREPARATIONS (may be covered for dual eligible)NIACIN SR 125MG, 250MG, 500MG 0 YSLO-NIACIN 250, 750MG 2 Y

C6Z-MULTIVITAMIN PREPARATIONS (may be covered for dual eligible)GENERIC EQUIVALENTS TO: ALLBEE C 0 Y BEROCCA PLUS 0 Y CENTRUM 0 Y OCUVITE 0 Y ONE-A-DAY & ONE-A-DAY W/IRON 0 Y STRESSTAB 600 FORMULA, WITH IRON AND WITH ZINC 0 Y THERAGRAN, THERAGRAN M & THERAGRAN H 0 Y UNICAP, UNICAP W/IRON, UNICAP M 0 Y VI-DAYLIN, VI-DAYLIN WITH IRON 0 YCENTRUM MULTIVITAMIN-MINERAL LIQUID 0 YCORVITE FREE 1.25-35 2 YDAILY MULTIVITAMIN WITH IRON 18MG-0.4MG 0 YDAILY VITAMIN FORMULA 0 YFOSFREE 175.5-14.5 0 YRENAX 35-2.5 2 YSTROVITE PLUS CAPLET 27-.8 2 Y

C7A-HYPERURICEMIA TX - PURINE INHIBITORSALLOPURINOL 100MG, 300MG 0 N

C7D-METABOLIC DEFICIENCY AGENTSCYSTADANE 1GM/1.7ML 2 N

C7F-APPETITE STIMULANTS FOR ANOREXIA, CACHEXIA, WASTING SYNDROMEMEGACE ES 625MG/5ML 2 N

Effective January 1, 2013 November 1, 2013

Page 14: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 14 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

C7H-PKU TX AGENT-COFACTOR OF PHENYLALANINE HYDROXYLASE KUVAN 100MG 2 N

C8A-METALLIC POISON ANTIDOTESCHEMET 100MG 2 NEXJADE 125MG, 250MG, 500MG 2 NFERRIPROX 500MG 2 NGALZIN 25MG, 50MG 2 NSYPRINE 250MG 2 N

D1A-PERIODONTAL COLLAGENASE INHIBITORS DOXYCYCLINE HYCLATE 20MG 0 N

D1D-DENTAL AIDS & PREPARATIONSCHLORHEXIDINE GLUCONATE SOLN 0 NTRIAMCINOLONE DENTAL PASTE 0 N

D2A-FLUORIDE PREPARATIONSPREVIDENT 5000 1.1% DRY MOUTH 2 NSODIUM FLUORIDE 0.25MG, .5MG, 1MG 0 NSODIUM FLUORIDE CREAM 1.1% 0 NSODIUM FLUORIDE DROPS 0.5MG/ML, 2.5MG/ML 0 N

D4B-ANTACIDS (may be covered for dual eligible if available over the counter)GENERIC EQUIVALENTS OF: GAVISCON 358-95/15ML, 20-80 0 Y MAALOX 400-400-40, 450-500-40 0 Y MYLANTA 200-200-20, 400-400-40 0 Y RIOPAN 540MG/5ML 0 YALUMINUM HYDROXIDE 600MG/5ML, 320MG/5ML 0 YCALCIUM CARBONATE 500MG/5ML 0 YSODIUM BICARBONATE 5GR, 10GR 0 Y

D4D-ANTIDIARRHEAL MICROORGANISMS AGENTS ACIDOPHILUS W/PECTIN LIQ 0 Y

D4E-ANTIULCER PREPARATIONSCARAFATE 1GM/10ML 0 NMISOPROSTOL 100MCG, 200MCG 0 NSUCRALFATE 1GM 0 N

D4F-ANTI-ULCER-H.PYLORI AGENTS HELIDAC 2 N

D4G-GASTRIC ENZYMESLACTRASE 250MG 2 N

D4J-PROTON-PUMP INHIBITORS LANSOPRAZOLE 15MG, 30MG 0 NLANSOPRAZOLE ODT 15MG, 30MG (AGES 0-6) * NOMEPRAZOLE CAPS 10MG, 20MG, 40MG 0 NOMEPRAZOLE TABS 20MG 0 NPANTOPRAZOLE 20MG, 40MG 0 NPREVACID 24H 15MG 0 NPRILOSEC OTC 0 NZEGERID OTC 0 N

Effective January 1, 2013 November 1, 2013

Page 15: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 15 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

D4N-ANTIFLATULENTS (may be covered for dual eligible if available over the counter)GAS-X 125MG 2 YSIMETHICONE 80MG TABS 0 YSIMETHICONE DROPS 40MG/0.6ML 0 Y

D6C-IRRITABLE BOWEL SYNDROME AGENT, 5HT-3 ANTAGONIST-TYPE LOTRONEX 0.5MG, 1MG 2 N

D6D-ANTIDIARRHEALS (may be covered for dual eligible if available over the counter)BISMUTH SUSPENSION 262MG/15ML, 525MG/15ML 0 YDIPHENOXYLATE/ATROPINE SULFATE TABS, LIQUID 0 NLOPERAMIDE HCL 2MG TABS, 1MG/5ML SOLN 0 NMOTOFEN TABS 2 N

D6F-DRUG TX-CHRONIC INFLAM. COLON DX, 5-AMINOSALICYLATEBALSALAZIDE DISODIUM 750 MG 0 N

D6S-LAXATIVES & CATHARTICS (may be covered for dual eligible if available over the counter)BISACODYL 5MG TABS 0 YCOLYTE 2 NDOCUSATE CALCIUM 240MG 0 YDOCUSATE SODIUM DROPS, LIQUID, SYRUP 150MG/15ML, 60MG/15ML 0 YDOCUSATE SODIUM CAPS 100MG, 250MG 0 YDOCUSATE SODIUM/CASANTHRANOL SYRUP, CAPS 300-100/5ML, 300-100 0 YFIBER LAXATIVE TABS 500MG, 625MG 0 YGLYCOLAX POWDER 2 YGOLYTELY SOLUTION 2 NLACTULOSE SYRUP 10GM/15ML 0 NMAGNESIUM CITRATE 0 YMILK OF MAGNESIA 400MG/5ML, 2400MG/10ML 0 YMIRALAX 2 YNULYTELY SOLUTION 2 NPEG-3350 0 NPOLYETHYLENE GLYCOL GRAN 0 YPSYLLIUM PREPARATIONS/VEGETABLE LAXATIVES 0 YSALINE-PHOSPHATE LAXATIVE ORAL LIQUID 0 YSENNA CONCENTRATES 8.6MG 0 YSENNA LIQUID 8.8MG/5ML 0 YSENNA W/DOCUSATE 8.6MG-50MG 0 YTRILYTE 2 N

D7A-BILE SALTSURSODIOL 250MG, 300MG, 500MG 0 N

D7L-BILE SALT SEQUESTRANTS CHOLESTYRAMINE LIGHT POWDER 0 NCHOLESTYRAMINE POWDER 0 NCOLESTIPOL 1G TABS 0 NPREVALITE POWDER 0 N

Effective January 1, 2013 November 1, 2013

Page 16: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 16 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

D8A-PANCREATIC ENZYMESCREON 3K-9.5K-15K, 30K-6K-19K, 60K-12K-38K, 120K-24K-76K, 180K-36K-114K 2 NPANCREAZE 4200, 10500, 16800, 21000 2 NPANCRELIPASE 5K 2 NZENPEP 3K, 5K, 10K, 15K, 20K, 25K 2 N

D9A-AMMONIA INHIBITORBUPHENYL POWDER 500MG 2 NCARBAGLU 200MG 2 NLACTULOSE 10GM/15ML 0 NLITHOSTAT 250MG 2 N

E0G-PRENATAL VITAMINS WITHOUT IRON (family planning)PRENAISSANCE NEXT 1.2-40-100 0 N

F1A-ANDROGENIC AGENTSANDRODERM 2MG/24H, 2.5MG/24H, 4MG/24H, 5MG/24H 2 NANDROGEL 12.5MG, 25MG, 50MG 1%, 1.62% 2 NANDROID 10MG 2 NAXIRON 30MG 2 NFLUOXYMESTERONE 10MG 0 NFORTESTA 10MG (2%) 2 NMETHITEST 10MG 2 NTESTIM 1% (50MG) 2 NTESTRED 20MG 2 N

G1A-ESTROGENIC AGENTSALORA 0.025MG/24HR, 0.05MG/24HR, 0.075MG/24HR, 0.1MG/24HR 2 NCENESTIN 0.3MG, 0.45MG, 0.625MG, 0.9MG, 1.25MG 2 NCOMBIPATCH 0.05-0.14/24 HR, 0.05-0.25/24 HR 2 NENJUVIA TABLET 0.3MG, 0.45MG, 0.625MG, 0.9MG, 1.25MG 2 NESTRADIOL 0.5MG, 1MG, 2MG 0 NESTRADIOL PATCH 0.025MG, 0.0375MG, 0.05MG, 0.06MG, 0.075MG, 0.1MGESTROPIPATE 0.625MG, 1.25MG, 2.5MG 0 NFEMHRT 1-0.005MG, 2.5MCG-0.5 2 NMENEST 0.3MG, 0.625MG, 1.25MG, 2.5MG 2 NNORETHINDRONE-ETHINYL ESTRADIOL 1-5 0 NPREMARIN 0.3MG, 0.45MG, 0.625MG, 0.9MG, 1.25MG 2 NPREMPHASE 0.625/5 2 NPREMPRO 0.3-1.5MG, 0.625/2.5, 0.625/5 2 NPREMPRO LOW DOSE 0.45MG-1.5MG 2 N

G2A-PROGESTATIONAL AGENTSAYGESTIN 5MG 2 NCRINONE 4%, 8% 2 NMEDROXYPROGESTERONE ACETATE 2.5MG, 5MG, 10MG 0 NNORETHINDRONE ACETATE 5MG 0 NPROMETRIUM 100MG, 200MG 0 N

G3A-OXYTOCICS (family planning)METHERGINE 0.2MG 0 NMETHYLERGONOVINE 0.2MG 0 N

Effective January 1, 2013 November 1, 2013

Page 17: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 17 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

G8A-CONTRACEPTIVES, ORAL (family planning)APRI 0.15-0.03 0 NARANELLE 7/9/5 0 NAVIANE 0.1-0.002 0 NAZURETTE 21-5 0 NBALZIVA 28 TABLET 0 NBEYAZ 3-0.02 0 NBREVICON 0.5-0.035MG 0 NCAMILA 0.35MG 0 NCAZIANT 7 DAYS X 3 0 NCESIA 7 DAYSX3 0 NCRYSELLE 0.3-0.03MG 0 NCYCLESSA 7-7-7 0 NDESOGEN 0.15/0.3 0 NELLA 30MG 0 NENPRESSE 6-5-10 0 NERRIN 0.35MG 0 NESTROSTEP 5-7-9-7 0 NETHINYL ESTRADIOL/DESOGESTREL 0.03/0.15 0 NETHINYL ESTRADIOL/DROSPIRENONE 0.03-3 0 NETHINYL ESTRADIOL/LEVONORGESTREL 0.03-0.15MG, 0.1-0.02, 90-20 0 NETHINYL ESTRADIOL/NORETHINDRONE 35MCG/0.5MG, 35MCG/0.4MG 0 NETHINYL ESTRADIOL/NORETHINDRONE 35MCG/1MG, 20MCG/3MG 0 NETHINYL ESTRADIOL/NORETHINDRONE/IRON 35MCG-0.4MG CHEW 0 NETHYNODIOL DIACETATA/ETHINYL ESTRADIOL 1/0.035 0 NGIANVI 0.02-3(24) 0 NJOLESSA 0.15 MG/0.03 MG TAB 0 NJOLIVETTE 0.35MG 0 NJUNEL 1-0.02MG, 1.5-0.03MG 0 NJUNEL FE 1.5-0.03MG, 1-0.02MG 0 NKARIVA 21-5 0 NLEENA 7-9-5 0 NLESSINA 0.1-0.02 0 NLEVONORGESTREL 0.75MG, 1.5MG 0 NLEVONORGESTROL/ETH ESTRADIOL 6-5-10 0 NLEVONORGESTROL/ETH ESTRADIOL 0.15/0.03MG-ETHINYL ESTRADIOL 0.01MG 0 NLEVORA 0.15/0.03 0 NLO/OVRAL 0.3/0.03 0 NLOESTRIN 1.5/0.03, 1/0.02 0 NLOESTRIN 24 FE 0 NLOESTRIN FE 1.5/30, 1/20 0 NLO LOESTRIN FE 1/10 0 NLOSEASONIQUE 0 NLUTERA 0.1-0.02 0 NLYBREL 90-20 MCG TABLET 0 NMESTRANOL/NORETHINDRONE 50MCG/1MG 0 N

Effective January 1, 2013 November 1, 2013

Page 18: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 18 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

MICROGESTIN 1.0-02MG, 1.5-0.03MG 0 NMICROGESTIN FE 1.5-0.035, 1.0-0.02 0 NMICRONOR 0.35MG 0 NMINASTRIN 24 FE CHEWABLE 1MG-20(24) 0 NMIRCETTE 21-5 0 NNATAZIA 3-2-1(28) 0 NNECON 10/11 0 NNECON 7 DAYS X 3 0 NNORA-BE 0.35MG 0 NNORDETTE 0.15/0.03 0 NNORETHINDRONE 0.35 0 NNORETHINDRONE/ETHINYL ESTRADIOL/FE FUMARATE 1.5-0.03, 1-0.02 0 NNORETHINDRONE/ETHINYL ESTRADIOL 0.5-0.035 0 NNORGESTIMATE/ETHINYL ESTRADIOL 0.25/0.035, 0.18-0.035/0.215-0.035/0.25-0.035 0 NNORGESTREL/ETHINYL ESTRADIOL 0.3/0.03 0 NNORTREL 7 DAYS X 3 0 NNORTREL 0.5-0.035,1.0-0.035 0 NOCELLA 0.03-3MG 0 NOGESTREL 0.5-0.05MG 0 NORTHO NOVUM 1/35, 7/7/7 0 NORTHO-CEPT 0.15/30 0 NORTHO-CYCLEN 0.25-0.035 0 NORTHO-TRI-CYCLEN 0 NORTHO-TRI-CYCLEN LO 7-7-7-LOW 0 NOVCON 1/0.05, 0.4/0.035 0 NPLAN B, PLAN B ONE-STEP 0 NPORTIA 0.15-0.03 0 NQUARTETTE 0.15MG 0 NQUASENSE 0.15/0.03 MG 0 NRECLIPSEN 0 NSAFYRAL 3-0.03 0 NSEASONALE 0 NSEASONIQUE 0 NSOLIA 0.15-0.03 0 NSPRINTEC 0.25-0.035MG 0 NSRONYX 0 NTILIA FE 5-7-9-7 0 NTRINESSA 7DAYS X 3 0 NTRI-NORINYL 7-9-5 0 NTRI-LEGEST FE 5-7-9-7 0 NTRI-PREVIFEM 7 DAYS X 3 0 NTRI-SPRINTEC 7 DAYS X 3 0 NVELIVET 7 DAYS X 3 0 NYASMIN 28 0 N

Effective January 1, 2013 November 1, 2013

Page 19: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 19 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

YAZ 0 NZENCHENT 0.4-0.035 0 NZOVIA 1/0.05MG, 1/0.035MG 0 N

G8F-CONTRACEPTIVE, TRANSDERMAL (family planning)ORTHO-EVRA 20-150/24HR 0 N

G9B- CONTRACEPTIVES, INTRAVAGINAL, SYSTEMIC (family planning)NUVA RING 0.12-0.015 0 N

H0B-LOCAL ANESTHETICSLIDOCAINE GEL 2% 0 NLIDOCAINE VISCOUS 2% 0 N

H0E-AGENTS TO TREAT MULTIPLE SCLEROSISAVONEX 30MCG 2 NBETASERON 0.3MG 2 NCOPAXONE 20MG 2 NGILENYA 0.5MG 2 NREBIF 22MCG/0.5ML,44MCG/0.5ML, TITRATION PACK (8.8MCG AND 22MCG) 2 N

BUTISOL SODIUM ELIXIR 30MG/5ML 2 YBUTISOL SODIUM TABS 30MG, 50MG 2 YPHENOBARBITAL 1/4GR, 1/2GR, 1GR, 1-1/2GR 0 NPHENOBARBITAL ELIXIR 20MG/5ML 0 NSECONAL SODIUM 100MG 2 Y

H2E-NON-BARB SEDATIVE-HYPNOTICCHLORAL HYDRATE SYRUP 500MG/5ML 0 NESTAZOLAM 1MG, 2MG 0 NFLURAZEPAM 15MG, 30MG 0 NMIDAZOLAM HCL SYRUP 2MG/ML, VIAL 5MG/ML 0 NSOMNOTE 500MG 0 NTEMAZEPAM 15MG, 30MG 0 NTRIAZOLAM 0.125MG, 0.25MG 0 NZALEPLON 5MG, 10MG 0 NZOLPIDEM 5MG, 10MG 0 N

H2F-ANTI-ANXIETY DRUGSALPRAZOLAM 0.25MG, 0.5MG, 1MG, 2MG 0 NBUSPIRONE 5MG, 7.5MG, 10MG, 15MG, 30MG 0 NCHLORDIAZEPOXIDE HCL 5MG, 10MG, 25MG 0 NCLORAZEPATE 3.75MG, 7.5MG, 15MG 0 NDIAZEPAM 2MG, 5MG, 10MG 0 NDIAZEPAM ORAL SOLN 5MG/ML, 5MG/5ML 0 NLORAZEPAM 0.5MG, 1MG, 2MG 0 NLORAZEPAM INTENSOL SOLN 2MG/ML 0 NMEPROBAMATE 200MG, 400MG 0 NOXAZEPAM 10MG, 15MG, 30MG 0 N

H2D-BARBITURATES (may be covered for dual eligible unless used for treatment of treatment of epilepsy, cancer, or chronic mental health disorders)

Effective January 1, 2013 November 1, 2013

Page 20: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 20 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

H2G-ANTI-PSYCHOTICS PHENOTHIAZINESCHLORPROMAZINE 10MG, 25MG, 50MG, 100MG, 200MG 0 NFLUPHENAZINE DECANOATE INJ 25MG/ML 0 NFLUPHENAZINE HCL 1MG, 2.5MG, 5MG, 10MG 0 NFLUPHENAZINE SOLN 2.5MG/5ML, 5MG/ML 0 NPERPHENAZINE 2MG, 4MG, 8MG, 16MG 0 NTHIORIDAZINE 10MG, 25MG, 50MG, 100MG 0 NTRIFLUOPERAZINE HCL 1MG, 2MG, 5MG, 10MG 0 N

H2M-ANTI-MANIA DRUGSEQUETRO 100MG, 200MG, 300MG 2 NLITHIUM CARBONATE 150MG, 300MG, 600MG 0 NLITHIUM CARBONATE SR 300MG, 450MG 0 NLITHIUM CITRATE SYRUP 8MEQ/5ML 0 NLITHOBID 300MG 2 N

H2S-SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRIS) CITALOPRAM 10MG/5ML 0 NCITALOPRAM HBR 10MG, 20MG, 40MG 0 NFLUOXETINE 10MG, 20MG, 40MG TABS, CAPS, 20MG/5ML 0 NFLUVOXAMINE MALEATE 25MG, 50MG, 100MG 0 NLEXAPRO 5MG, 20MG, 5MG/5ML 2 NPAROXETINE HCL 10MG, 20MG, 30MG, 40MG, 10MG/5ML 0 NSERTRALINE 25MG, 50MG, 100MG, 20MG/ML 0 N

H2U-TRICYCLIC ANTIDEPRESSANTS & REL. NON-SEL. RU-INHIB AMITRIPTYLINE HCL 10MG, 25MG, 50MG, 75MG, 100MG, 150MG 0 NAMOXAPINE 25MG, 50MG, 100MG, 150MG 0 NCLOMIPRAMINE 25MG, 50MG, 75MG 0 NDESIPRAMINE 10MG, 25MG, 50MG, 75MG, 100MG, 150MG 0 NDOXEPIN HCL 10MG, 25MG, 50MG, 75MG, 100MG, 150MG, 10MG/ML 0 NIMIPRAMINE HCL 10MG, 25MG, 50MG 0 NIMIPRAMINE PAMOATE 75MG, 100MG, 125MG, 150MG 0 NMAPROTILINE 25MG, 50MG, 75MG 0 NNORTRIPTYLINE 10MG, 25MG, 50MG, 75MG, 10MG/5ML ORAL 0 NPROTRIPTYLINE 5MG, 10MG 0 NSURMONTIL 25MG, 50MG, 100MG 2 NVIVACTIL 5MG, 10MG 2 N

H2V-TX FOR ATTENTION DEFICIT-HYPERACT(ADHD)/NARCOLEPSY FOCALIN 2.5MG, 5MG, 10MG (AGE 6 AND OVER) 0 NFOCALIN XR 5MG, 10MG, 15MG, 20MG, 25MG, 30MG, 35MG, 40MG (AGE 6 AND OVER) 2 NMETADATE CD 10MG, 20MG, 30MG, 40MG, 50MG, 60MG (AGE 5 AND OVER) 2 NMETHYLIN 5MG/5ML, 10MG/5ML (AGE 5 AND OVER) 2 NMETHYLIN ER 10MG (AGE 5 AND OVER) 2 N

METHYLPHENIDATE HCL 5MG, 10MG, 20MG, 5MG/ML, 10MG/ML (AGE 5 AND OVER) 0 NMETHYLPHENIDATE ER (24 HOUR) 18MG, 27MG, 36MG, 54MG (AGE 6 AND OVER) 0 NMETHYLPHENIDATE SR 20MG (AGE 5 AND OVER) 0 N

Effective January 1, 2013 November 1, 2013

Page 21: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 21 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

H2W-TRICYCLIC ANTIDEPRESSANT/PHENOTHIAZINE COMBINATNS AMITRIPTYLINE/PERPHENAZINE 10/2, 10/4, 25/2, 25/4, 50/4 0 N

H2X-TRICYCLIC ANTIDEPRESSANT/BENZODIAZEPINE COMBINATNS AMITRIPTYLINE/CHLORDIAZEPOXIDE 12.5/5, 25/10 0 N

H3A-NARCOTIC ANALGESICSBELLADONNA/OPIUM SUPPS 30-16.2MG, 60-16.2 0 NBUTORPHANOL NS 10MG/ML 0 NFENTANYL PATCH 12MG, 25MCG, 50MCG, 75MCG, 100MCG 0 NHYDROCODONE/APAP 2.5-167/5ML, 2.5-500 0 NHYDROCODONE/APAP 5-325, 5-500 0 NHYDROCODONE/APAP 7.5-325, 7.5-500, 7.5-650, 7.5-750 0 NHYDROCODONE/APAP 10-325, 10-500, 10-650, 10-660, 10-750 0 NHYDROMORPHONE SUPPS 3MG 0 NMEPERIDINE SYRUP 50MG/5ML 0 NMETHADONE SOLN 5MG/5ML, 10MG/5ML, 10MG/ML CONC SOLN 0 NMETHADOSE 10MG/ML 0 NMORPHINE SULFATE ER 15MG, 30MG, 60MG, 100MG, 200MG 0 NMORPHINE SULFATE SOLN 10MG/5ML, 20MG/ML, 20MG/5ML 0 NMORPHINE SULFATE SUPPS 5MG, 10MG, 20MG, 30MG 0 NOXYCODONE HCL 5MG/5ML, 20MG/ML 0 NOXYCODONE HCL/ACETA 2.5-325, 5-325, 5-500, 7.5-325, 7.5-500, 10-325, 10-650 0 NOXYCODONE HCL/OXY T/ASA 4.5/0.38/325 0 NROXICET ORAL SOLN 5MG/325MG 0 NTRAMADOL 50MG 0 N

ASPIRIN EC 81MG, 325MG 0 YCHOLINE MAGNESIUM TRISALICYLATE 500MG, 750MG 0 NCHOLINE MAGNESIUM TRISALICYLATE LIQUID 500MG/5ML 0 NMAGNESIUM SALICYLATE 600MG 0 NSALSALATE 500MG, 750MG 0 N

ACETAMINOPHEN SUPPOSITORIES 120MG, 325MG, 650MG 0 YH3F-ANTIMIGRAINE PREPARATIONS

CAFERGOT 1-100MG 2 NCAFFEINE-ERGOTAMINE SUPPOSITORIES 0 NERGOTAMINE/CAFFEINE TABS 1-100MG 0 NIMITREX INJ 4MG/0.5ML, 6MG/0.5ML 0 NIMITREX NASAL 5MG, 20MG 0 NMAXALT-MLT 5MG, 10MG 0 NMIGRANAL NASAL 0.5MG/SPRAY 2 NNARATRIPTAN 1MG, 2.5MG 0 NRIZATRIPTAN 5MG, 10MG 0 NSUMATRIPTAN 25MG, 50MG, 100MG 0 N

H3D-ANALGESIC/ANTIPYRETICS, SALICYLATES (may be covered for dual eligible if available over the counter)

H3E-ANALGESIC, ANTIPYRETIC-NON-SAL (may be covered for dual eligible if available over the counter)

Effective January 1, 2013 November 1, 2013

Page 22: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 22 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

ACETAMINOPHEN/BUTALBITAL 325MG/50MG, 650MG/50MG 0 YPHRENILIN FORTE 2 Y

BUTALBITAL/ACETAMINOPHEN/CAFFEINE 325/40/50 CAP, TAB 0 YBUTALBITAL/ACETAMINOPHEN/CAFFEINE 500-40-50 TAB 0 Y

H3T-NARCOTIC ANTAGONISTSNALTREXONE HCL 50MG 0 N

H3U-NARCOTIC ANALGESIC & NON-SALICYLATE ANALGESIC COMB ACETAMINOPHEN/CODEINE 15-300, 30-300, 60-300 0 NACETAMINOPHEN/CODEINE ELIXIR 120-12MG/5ML 0 N

H4B-ANTICONVULSANTSBANZEL 200MG, 400MG, 40MG/ML 2 NCARBAMAZEPINE 100MG, 200MG, 100MG/5ML 0 NCARBATROL 100MG, 200MG, 300MG 2 0 NCELONTIN 300MG 2 NCLONAZEPAM 0.5MG, 1MG, 2MG 0 NDEPAKENE 250MG (BMN ONLY) 2 NDEPAKENE SYRUP 250MG/5ML (BMN ONLY) 2 NDIASTAT ACUDIAL 2.5, 10, 20 2 0 NDILANTIN 30MG, 50MG CHEWABLE, 100MG 2 NDILANTIN SUSP 125MG/5ML 2 NDIVALPROEX SODIUM 125MG TAB, 125MG SPRINKLE CAP, 250MG, 500MG 0 NDIVALPROEX SODIUM ER 250MG, 500MG 0 NETHOSUXIMIDE 250MG, SYRUP 250MG/5ML 0 NFELBATOL 400MG, 600MG 2 NFELBATOL SUSP 600MG/5ML 2 NGABAPENTIN 100MG, 300MG, 400MG, 600MG, 800MG, 250MG/5ML 0 NGABITRIL 2MG, 4MG, 12MG, 16MG 2 NKEPPRA XR 500MG, 750MG 2 NLAMICTAL ODT 25MG, 50MG, 100MG, 200MG, 25(21)-50, 50(42)-100, 25-50-100 2 NLAMICTAL STARTER KIT ORANGE, BLUE, GREEN 2 NLAMICTAL XR 25MG, 50MG, 100MG, 200MG, 250MG, STARTER KIT ORANGE, BLUE, GREEN 2 NLAMOTRIGINE DISPER TAB 5MG, 25MG 0 NLAMOTRIGINE TAB 25MG, 100MG, 150MG, 200MG, STARTER KIT 0 NLEVETIRACETAM 250MG, 500MG, 750MG, 1000MG, 100MG/ML 0 NLYRICA 25MG, 50MG, 75MG, 100MG, 150MG, 200MG, 225MG, 300MG 2 NMEBARAL 32MG, 50MG, 100MG 2 NMEPHOBARBITAL 32MG, 50MG, 100MG 0 NMYSOLINE 250MG (BMN ONLY) 2 NMYSOLINE 50MG 2 NNEURONTIN 250MG/5ML 2 N

H3K-ANALGESIC, NON-SALICYLATE & BARBITURATE COMB. (barbiturates may be covered for dual eligible unless used for treatment of treatment of epilepsy, cancer, or chronic mental health disorders)

H3L-ANALGESIC,NON-SALICYLATE,BARBITURATE,&XANTHINE CMB (barbiturates may be covered for dual eligible unless used for treatment of treatment of epilepsy, cancer, or chronic mental health disorders)

Effective January 1, 2013 November 1, 2013

Page 23: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 23 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

ONFI 5MG, 10MG, 20MG 2 NOXCARBAZEPINE 150MG, 300MG, 600MG, 300MG/5ML 0 NPEGANONE 250MG 2 NPHENYTEK 200MG, 300MG 2 NPHENYTOIN SODIUM 100MG, ER100MG 0 NPHENYTOIN SODIUM EXTENDED 200MG, 300MG 0 NPHENYTOIN SUSP 125MG/5ML 0 NPRIMIDONE 250MG 0 NPRIMIDONE 50MG 0 NSABRIL 500MG PACKETS, TABLETS 2 NTEGRETOL 100MG, 200MG (BMN ONLY) 2 NTEGRETOL SUSP 100MG/5ML (BMN ONLY) 2 NTEGRETOL XR 100MG, 200MG, 400MG 2 0 NTOPIRAMATE 25MG, 50MG, 100MG, 200MG 0 NTOPIRAMATE SPRINKLE 15MG, 25MG 0 NTRILEPTAL 300MG/5ML 2 NVALPROIC ACID 250MG 0 NVALPROIC ACID SYRUP 250MG/5ML 0 NVIMPAT 50MG, 100MG, 150MG, 200MG, 10 MG/ML 2 NZARONTIN 250MG 0 NZARONTIN SYRUP 250MG/5ML 2 NZONISAMIDE 25MG, 50MG, 100MG 0 N

H6A-ANTIPARKINSON DRUGS, OTHERAMANTADINE HCL 100MG 0 NAMANTADINE SYRUP 50MG/5ML 0 NBROMOCRIPTINE 2.5MG, 5MG 0 NCARBIDOPA/LEVODOPA 10/100, 25/100, 25/250 0 NCARBIDOPA/LEVODOPA CR 25/100, 50/200 0 NCOMTAN 200MG 2 NENTACAPONE 200MG 0 NPARLODEL 2.5MG, 5MG 2 NPRAMIPEXOLE 0.125MG, 0.25MG, 0.5MG, 0.75MG, 1MG, 1.5MG 0 NROPINIROLE 0.25MG, 0.5MG, 1MG, 2MG, 3MG, 4MG, 5MG 0 NSELEGILINE HCL 5MG 0 N

H6B-ANTIPARKINSONISM DRUGS, ANTICHOLINERGIC BENZTROPINE 0.5MG, 1MG, 2MG 0 NTRIHEXIPHENIDYL HCL 2MG, 5MG, 2MG/5ML 0 N

H6C-ANTITUSSIVE NON-NARC (may be covered for dual eligible)BENZONATATE 100MG, 200MG 0 YDELSYM 30MG/5ML 2 YDEXTROMETHORPHAN HBR 5MG/5ML, 15MG/5ML 0 YROBITUSSIN PEDIATRIC 7.5MG/5ML 2 Y

H6H-SKELETAL MUSCLE RELAXANTSBACLOFEN 10MG, 20MG 0 NCHLORZOXAZONE 250MG, 500MG 0 NCYCLOBENZAPRINE 5MG, 10MG 0 N

Effective January 1, 2013 November 1, 2013

Page 24: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 24 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

DANTROLENE 25MG, 50MG, 100MG 0 NMETHOCARBAMOL 500MG, 750MG 0 NTIZANIDINE HCL 2MG, 4MG 0 N

H6J-ANTIEMETIC/ANTIVERTIGO AGENTSANTI-NAUSEA LIQUID 0 NCESAMET 1MG 2 NDIMENHYDRINATE 50MG 0 NEMEND 40MG, 80MG, 125MG, 125-80 2 NMARINOL 2.5MG, 5MG, 10MG 0 NMECLIZINE 12.5MG, 25MG CHEWABLE, 25MG 0 NONDANSETRON 4MG, 8MG, 24MG 0 NONDANSETRON ODT 4MG, 8MG 0 NONDANSETRON ORAL SOLUTION 4MG/5ML 0 NPROCHLORPERAZINE MALEATE 5MG, 10MG 0 NPROCHLORPERAZINE MALEATE SUPP 25MG 0 NPROMETHAZINE SUPPS, 12.5MG, 25MG, 50MG 0 NTRANSDERM SCOP PATCH 1.5MG/72HRS 2 NTRIMETHOBENZAMIDE HCL 300MG 0 N

H6L-MOVEMENT DISORDERS (DRUG THERAPY) XENAZINE 12.5MG, 25MG 2 N

H7B-ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE 7.5MG, 15MG, 30MG, 45MG 0 NMIRTAZAPINE RAPID DISSOLVE TABLET 15MG, 30MG, 45MG 0 N

H7C-SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS) VENLAFAXINE HCL 25MG, 37.5MG, 50MG, 75MG, 100MG TABS 0 NVENLAFAXINE ER CAPSULE 37.5MG, 75GM, 150MG 0 N

H7D-NOREPINEPHRINE AND DOPAMINE REUPTAKE INHIB (NDRIS) BUPROPION HCL 75MG, 100MG 0 NBUPROPION SR 100MG, 150MG, 200MG 0 NBUPROPION XL 150MG, 300MG 0 N

H7E-SEROTONIN-2 ANTAGONIST/REUPTAKE INHIBITORS (SARIS) NEFAZODONE HCL 50MG, 100MG, 150MG, 200MG, 250MG 0 NTRAZODONE HCL 50MG, 100MG, 150MG 0 N

H7J-MAOIS - NON-SELECTIVE & IRREVERSIBLE H7N-SMOKING DETERRENTS, OTHER

BUPROPION SR 150MG 0 NH7O-ANTIPSYCHOTICS, DOPAMINE ANTAGONISTS, BUTYROPHENONES

HALDOL DECANOATE 50MG/ML, 100MG/ML 2 NHALOPERIDOL 0.5MG, 1MG, 2MG, 5MG, 10MG, 20MG 0 NHALOPERIDOL DECANOATE 50MG/ML, 100MG/ML 0 NHALOPERIDOL LACTATE CONC LIQUID 2MG/ML 0 N

H7P-ANTIPSYCHOTICS,DOPAMINE ANTAGONISTS, THIOXANTHENES NAVANE 20MG 2 NTHIOTHIXENE 1MG, 2MG, 5MG, 10MG 0 N

H7R-ANTIPSYCH, DOPAMINE ANTAGONIST, DIPHENYLBUTYLPIPERIDINES ORAP 1MG, 2MG 2 N

Effective January 1, 2013 November 1, 2013

Page 25: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 25 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

H7S-ANTIPSYCHOTICS, DOPAMINE ANTAGONIST, DIHYDROINDOLONES MOBAN 10MG, 25MG, 50MG 2 N

H7T-ANTIPSYCHOTICS, ATYPICAL,DOPAMINE, & SEROTONIN ANTAG INVEGA SUSTENNA 39MG, 78MG, 117MG, 156MG, 234MG 0 NQUETIAPINE 25MG, 50MG, 100MG, 200MG, 300MG, 400MG 0 NRISPERDAL CONSTA 12.5MG, 25MG, 37.5MG, 50MG 0 NRISPERIDONE 0.25MG, 0.5MG, 1MG, 2MG, 3MG, 4MG, 1MG/ML 0 NRISPERIDONE ODT 0.25MG, 0.5MG, 1MG, 2MG, 3MG, 4MG 0 NZIPRASIDONE 20MG, 40MG, 60MG, 80MG 2 NZYPREXA RELPREVV 210MG, 300MG, 405MG 0 N

H7U-ANTIPSYCHOTICS, DOPAMINE & SEROTONIN ANTAGONISTS LOXAPINE SUCCINATE 5MG, 10MG, 25MG, 50MG 0 N

H7X-ANTIPSYCHOTICS, ATYP, D2 PARTIAL AGONIST/5HT MIXED ABILIFY MAINTENA 300MG, 400MG 0 N

H7Y-TX FOR ATTENTION DEFICIT-HYPERACT.(ADHD), NRI-TYPE STRATTERA 10MG, 18MG, 25MG, 40MG, 60MG, 80MG, 100MG (AGE 6 AND OLDER) 2 N

H7Z-SSRI &ANTIPSYCH, ATYP, DOPAMINE & SEROTONIN ANTAG COMB H8M-TX FOR ADHD - SELECTIVE ALPHA-2 RECEPTOR AGONIST

INTUNIV ER 1MG, 2MG, 3MG, 4MG 2 NH8O-PSEUDOBULBAR AFFECT (PBA) AGENTS, NMDA ANTAGONISTS

NUEDEXTA 20-10 2 NH8P-SSRI & SEROTONIN PARTIAL AGONIST ANTIDEPRESSANT J1A-PARASYMPATHETIC AGENTS

BETHANECHOL CHLORIDE 5MG, 10MG, 25MG, 50MG 0 NEVOXAC 30MG 2 NGUANIDINE HCL 125MG 2 NPILOCARPINE HCL 5MG, 7.5MG 0 NSALAGEN 5MG 2 N

J1B-CHOLINESTERASE INHIBITORSDONEPEZIL 5MG, 10MG 0 NDONEPEZIL ODT 5MG, 10MG 0 NEXELON 1.5MG, 3MG, 4.5MG, 6MG, 2MG/ML 0 NGALANTAMINE 4MG, 8MG, 12MG, 4MG/ML 0 NGALANTAMINE ER 8MG, 16MG, 24MG 0 NMESTINON 180MG 2 NMESTINON 60MG/5ML LIQUID 2 NMYTELASE 10MG 2 NPROSTIGMIN 15MG 2 NPYRIDOSTIGMINE BROMIDE 60MG 0 N

J2A-BELLADONNA ALKALOIDSHYOMAX-FT 0.125MG 2 NHYOMAX-SL 0.125MG 2 NHYOSCYAMINE 0.125MG 0 NHYOSCYAMINE 0.125MG, 0.25MG RAPID DISSOLVE 0 NHYOSCYAMINE 0.125MG/ML, 0.125MG/5ML 0 NHYOSCYAMINE SR 0.375MG 0 N

Effective January 1, 2013 November 1, 2013

Page 26: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 26 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

METHSCOPOLAMINE BROMIDE 2.5MG 0 NNULEV 0.125MG 2 NSYMAX 0.125MG 2 N

J2B-ANTICHOLINERGIC, QUATERNARY AMMONIUM CUVPOSA 1MG/5ML 2 NCANTIL 25MG 2 NGLYCOPYRROLATE 1MG, 2MG 0 NPROPANTHELINE 15MG 0 N

J2D-ANTICHOLINERGIC ANTISPASMODICSDICYCLOMINE HCL 10MG, 20MG, 10MG/5ML 0 N

J3A-SMOKING DETERRENT AGENTS (GANGLIONIC STIM, OTHERS) COMMIT 2MG, 4MG 2 NNICODERM CQ PATCH 7MG/24HR, 14MG/24HR, 21MG/24HR 0 NNICORETTE GUM 2MG, 4MG 2 NNICOTINE GUM 2MG, 4MG 0 NNICOTINE LOZENGE 2MG, 4MG 0 NNICOTINE PATCH 7MG/24HR, 14MG/24HR, 21MG/24HR 0 NNICOTROL INHALER 2 NNICOTROL NASAL SPRAY 2 N

J3C-SMOKING DETERRENT-NICOTINIC RECEPT.PARTIAL AGONISTCHANTIX 0.5MG, 1MG, MONTH PAK 2 N

J5B-ADRENERGICS, AROMATIC, NON-CATECHOLAMINE ADDERALL XR 5MG, 10MG, 15MG, 20MG, 25MG, 30MG 0 NAMPHETAMINE SALT COMBO 5MG, 7.5MG, 10MG, 12.5MG, 15MG, 20MG, 30MG 0 NVYVANSE 20MG, 30MG, 40MG, 50MG, 60MG, 70MG 2 N

J5D-BETA ADRENERGIC AGENTSACCUNEB (AGE 0 TO 12 ONLY) 0.21MG/ML, 0.42MG/ML * NALBUTEROL (AGE 0 TO 12 ONLY) 0.21MG/ML, 0.42MG/ML * NALBUTEROL 0.83MG/ML SOLN FOR INH 0 NALBUTEROL 2MG, 4MG 0 NALBUTEROL 2MG/5ML SYRUP 0 NALBUTEROL 5MG/ML SOLN FOR INH 0 NALBUTEROL ER 4MG, 8MG 0 NMETAPROTERENOL 10MG, 20MG 0 NMETAPROTERENOL 10MG/5ML SYRUP 0 NPROAIR HFA 0 NPROVENTIL HFA 2 NTERBUTALINE SO4 2.5MG, 5MG 0 NVENTOLIN HFA 2 N

J5E-SYMPATHOMIMETIC AGENTSEPHEDRINE SULFATE 25MG 0 NPHENYLEPHRINE HCL 10MG 0 NPSEUDOEPHEDRINE HCL 30MG, 60MG 0 NPSEUDOEPHEDRINE HCL 15MG/5ML, 30MG/5ML 0 N

Effective January 1, 2013 November 1, 2013

Page 27: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 27 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

J5F-ANAPHYLAXIS THERAPY AGENTS ADRENACLICK 0.15MG, 0.3MG 2 NAUVI-Q 0.15MG, 0.3MG 2 NEPINEPHRINE AUTO-INJECTOR 0.15MG, 0.3MG 0 NEPIPEN, EPIPEN JR 0.15MG 2 NTWINJECT 0.15MG/0.15ML, 0.3MG/0.3ML 2 N

J5H-ADRENERGIC VASOPRESSOR AGENTS MIDODRINE HCL 2.5MG, 5MG, 10MG 0 N

J5J-BETA-ADRENERGIC AND ANTICHOLINERGIC COMBINATIONS COMBIVENT 103-18MCG 2 NIPRATROPIUM - ALBUTEROL NEBULIZER SOLUTION 0.5MG-3MG/3ML 0 N

J7A-ALPHA/BETA-ADRENERGIC BLOCKING AGENTSCARVEDILOL TABLETS 3.125MG, 6.25MG, 12.5MG, 25MG 0 NLABETALOL 100MG, 200MG, 300MG 0 N

J7B-ALPHA-ADRENERGIC BLOCKING AGENTS DOXAZOSIN MESYLATE 1MG, 2MG, 4MG, 8MG 0 NPRAZOSIN HCL 1MG, 2MG, 5MG 0 NTERAZOSIN HCL 1MG, 2MG, 5MG, 10MG 0 N

J7C-BETA ADRENERGIC BLOCKERSACEBUTOLOL 200MG, 400MG 0 NATENOLOL 25MG, 50MG, 100MG 0 NBETAXOLOL HCL 10MG, 20MG 0 NBISOPROLOL FUM 5MG, 10MG 0 NMETOPROLOL SUCCINATE 25MG, 50MG, 100MG, 200MG 0 NMETOPROLOL TARTRATE 25MG, 50MG, 100MG 0 NNADOLOL 20MG, 40MG, 80MG 0 NPINDOLOL 5MG, 10MG 0 NPROPRANOLOL 20MG/5ML, 40MG/5ML SOLN 2 NPROPRANOLOL HCL 10MG, 20MG, 40MG, 60MG, 80MG 0 NPROPRANOLOL LA 60MG, 80MG, 120MG, 160MG 0 NSOTALOL 80MG, 120MG, 160MG, 240MG 0 NTIMOLOL MALEATE 5MG, 10MG, 20MG 0 N

J7H-BETA-ADRENERGIC BLOCKING AGENTS/THIAZIDE & RELATED ATENOLOL/CHLORTHALIDONE 25/50, 25/100 0 NBISOPROLOL FUMARATE/HCTZ 6.25/2.5, 6.25/5, 6.25/10 0 NDUTOPROL 25/12.5MG, 50/12.5MG, 100/12.5MG 2 NMETOPROLOL/HCTZ 50/25, 100/25, 100/50 0 NNADOLOL/BENDROFLUMETHIAZIDE 40-5MGMG, 80-5MG 0 NPROPRANOL/HCTZ 25/40, 25/80 0 N

J9A-INTESTINAL MOTILITY STIMULANTSMETOCLOPRAMIDE HCL 5MG, 10MG 0 NMETOCLOPRAMIDE HCL 5MG/5ML ORAL SOLN 0 N

L0B-TOPICAL/MUCOUS MEMBRANE/SUBCUTANEOUS ENZYMESANTYL 2 N

L1A-ANTIPSORIATIC AGENTS, SYSTEMIC SORIATANE 10MG, 17.5MG, 22.5MG, 25MG 2 N

Effective January 1, 2013 November 1, 2013

Page 28: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 28 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

L2A-EMOLLIENTSAMERIPHOR MOIST OINTMENT 0 NAMMONIUM LACTATE 12% CREAM, LOTION 0 NATRAC-TAIN 10% 2 NDERMAPHOR OINTMENT 0 NKERI ORIGINAL MOIST THERAPY LOTION, SENSITIVE SKIN LOTION 2 NMINERIN CREME 0 NNOURIVA REPAIR CREAM 0 NPETROLATUM BASE OINTMENT 0 N

L3A-PROTECTIVES (may be covered for dual eligible if available over the counter)ALOE VESTA 2 YBAZA PROTECT 2 YDERMAPHOR 44% 2 YDERMAGRAN OINT, SPRAY 2 YDERMAMED OINT 2 YPELEVERUS, PELEVERUS CLEAR, PELEVERUS WOUND SPRAY 2 YREMEDY SKIN REPAIR CREAM 1.5% 2 YSENSI-CARE MOIST BARRIER OINT, PROTECT BARRIER OINT 2 Y

L3P-ANTIPRURITICS TOPICALDIPHENHYDRAMINE 2% CREAM 0 NPRUDOXIN 5% 2 NZONALON 5% 2 N

L5A-KERATOLYTICSBENZOYL PEROXIDE CLEANSER 6%, 9% 0 NBENZOYL PEROXIDE CREAMY WASH 4%, 8% 0 NBENZOYL PEROXIDE GEL 2.5%, 4%, 5%, 8%, 10% 0 NBENZOYL PEROXIDE LOTION 4%, 5%, 10% 0 NBENZOYL PEROXIDE WASH 2.5%, 5%, 10% 0 NCARMOL 40% CREAM, LOTION, GEL 2 NCONDYLOX GEL 0.5% 2 NCONDYLOX TOP SOLN 0.5% 0 NHYDRISALIC GEL 2 NKEROL 50%, AD 45% EMULSION 2 NPANOXYL 10% 2 NREMEVEN 50% CREAM 2 NSAL-PLANT GEL 17% 2 NSALACTIC FILM 16.7% 2 NSALICYLIC ACID 3%, 6% SHAMPOO 0 NSALICYLIC ACID 6% CREAM KIT 0 NSALICYLIC ACID 6% LOTION KIT 0 NSEBULEX SHAMPOO 2%-2% 2 NUREA CLOTHS 42% 0 NUREA CREAM, GEL 40% 0 NUREA EMULSION 50% 0 N

Effective January 1, 2013 November 1, 2013

Page 29: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 29 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

UREA LOTION 35% 0 NUREA NAILSTICK 50% 2 NUREA TOPICAL SUSPENSION 50% 0 N

L5E-ANTISEBORRHEIC AGENTS SELENIUM SULFIDE 1% SHAMPOO, 2.5% LOTION, SHAMPOO 0 N

L5F-ANTIPSORIATICSCALCIPOTRIENE 0.005% OINTMENT, SOLUTION 0 NDOVONEX CREAM, SOLN 0.005% 2 NTAZORAC GEL 0.05%, 0.1%(AGES 0-23) 2 N

L5G-ROSACEA AGENTS, TOPICAL METROGEL 1% 2 NMETROLOTION 0.75% 2 NMETRONIDAZOLE 0.75% TOPICAL CREAM, GEL 0 NNORITATE 1% 2 N

L5H-ACNE AGENTS, TOPICALAZELEX 20% CREAM 2 NBENZACLIN 1-5% PUMP 2 NCLINDAMYCIN /BENZOYL PEROXIDE GEL 1%-5% 0 NKLARON LOTION 10% 0 N

L6A-IRRITANTS/COUNTER-IRRITANTS BETATAR SHAMPOO 2.5% 0 NCAPSAICIN 0.025%, 0.075%, 0.1% CREAM 0 NZIKS OINT 2 N

L9A-MISC TOPICAL AGENTSUREA CREAM, LOTION 10% 0 NUREA LOTION 40% 0 NWOUN'DRES 2 N

L9B-VITAMIN A DERIVATIVES RETIN A MICRO 0.04%, 0.1% (AGES 0-23) 2 NTRETINOIN CREAM 0.025%, 0.05%, 0.1% (AGES 0-23) 0 NTRETINOIN GEL 0.01%, 0.025% (AGES 0-23) 0 N

M0C-BLOOD FACTORS,MISCELLANEOUS CORIFACT KIT 2 N

M0E-ANTIHEMOPHILIC FACTORS ADVATE 2 NALPHANATE 2 NBIOCLATE 2 NFEIBA NF 2 NFEIBA VH IMMUNO 2 NHELIXATE FS 2 NHEMOFIL-M 2 NHEMOFIL-T 2 NHUMATE-P 2 NKOATE-DVI 2 NKOGENATE FS 2 NMONOCLATE-P 2 N

Effective January 1, 2013 November 1, 2013

Page 30: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 30 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

NOVOSEVEN RT 2 NRECOMBINATE 2 NXYNTHA KIT, SOLOFUSE 2 N

M0F-FACTOR IX PREPARATIONS BEBULIN VH IMMUNO 2 NBENEFIX 2 NMONONINE 2 NPROFILNINE SD 2 NPROPLEX SX 2 N

M4D-ANTIHYPERLIPIDEMIC - HMG COA REDUCTASE INHIBITORS ATORVASTATIN 10MG, 20MG, 40MG, 80MG 0 NLOVASTATIN 10MG, 20MG, 40MG 0 NPRAVASTATIN 10MG, 20MG, 40MG, 80MG 0 NSIMVASTATIN 5MG, 10MG, 20MG, 40MG, 80MG 0 N

M4E-LIPOTROPICSANTARA 43MG, 130MG 2 NFISH OIL 340-1000, 360-1200, 435-880, 500-1000, 1000 0 NGEMFIBROZIL 600MG 0 NNIASPAN 500MG, 750MG, 1000MG 2 NTRICOR 48MG, 145MG 2 0 NTRILIPIX 45MG, 135MG 2 N

M4G-HYPERGLYCEMICSGLUCACON 1MG, EMERGENCY KIT 1MG 2 NGLUCOSE 4G CHEWABLE 0 NPROGLYCEM 50MG/ML 2 N

M4L-ANTIHYPERLIPIDEMIC-HMG COA REDUCTASE INHIB.&NIACIN SIMCOR 500-20, 500-40, 750-20, 1000-20, 1000-40 2 N

M9D-ANTIFIBRINOLYTIC AGENTSAMICAR 250MG/ML SYRUP 0 NAMICAR 500MG, 1000MG 2 NLYSTEDA 650MG 2 N

M9K-HEPARIN AND RELATED PREPARATIONSFRAGMIN 2500U, 5000U 2 NFRAGMIN 7500U, 10000U, 12500U, 15000U, 18000U, 25000U 2 NHEPARIN 10U/ML, 100U/ML 0 NLOVENOX 30MG, 40MG, 60MG, 80MG, 100MG, 120MG, 150MG INJ 2 N

M9L-ANTICOAGULANTS, COUMARIN TYPE WARFARIN SODIUM 1, 2, 2.5, 3, 4, 5, 6, 7.5, 10 0 N

M9P-PLATELET AGGREGATE INHIBAGGRENOX 25-200MG 2 NBRILINTA 90MG 2 NCILOSTAZOL 50MG, 100MG 0 NCLOPIDOGREL 75MG 0 NDIPYRIDAMOLE 25MG, 50MG, 75MG 0 NEFFIENT 5MG, 10MG 2 NTICLOPIDINE 250MG 0 N

Effective January 1, 2013 November 1, 2013

Page 31: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 31 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

M9S-HEMORRHEOLOGIC AGENTSPENTOXIFYLLINE 400MG 0 N

M9V-DIRECT FACTOR XA INHIBITORS XARELTO 10MG, 15MG, 25MG 2 N

N1C-LEUKOCYTE STIMULANTSLEUKINE 250MCG, 500MCG INJ 2 NNEULASTA 6MG/0.6ML 2 NNEUPOGEN 300MCG/ML, 600MCG/ML INJ 2 N

N1D-PLATELET REDUCING AGENTS ANAGRELIDE HCL 0.5MG, 1MG 0 N

N1E-PLATELET PROLIFERATION STIMULANTS NEUMEGA 5MG INJ 2 N

NIF-THROMBOPOIETIN RECEPTOR AGONISTS PROMACTA 25MG, 50MG, 75MG 2 N

P1B-SOMATOSTATIC AGENTSOCTREOTIDE 0.05MG/ML, 0.1MG/ML, 0.2MG/ML, 0.5MG/ML, 1MG/ML 0 N

P1F-PITUITARY SUPPRESSIVE AGENTSCABERGOLINE 0.5MG 0 NDANAZOL 50MG, 100MG, 200MG 0 NDANOCRINE 50MG, 100MG, 200MG 2 N

P1M-LHRH (GNRH) AGONIST ANALOG PITUITARY SUPPRESSANTS SYNAREL 2MG/ML NASAL SOLN 2 N

P2B-ANTIDIURETIC AND VASOPRESSOR HORMONESDDAVP 0.1MG, 0.2MG 2 NDDAVP 4MCG/ML INJ 2 NDDAVP NASAL 0.01%, SPRAY PUMP 10MCG/DOSE 2 NDESMOPRESSIN ACETATE INJ 4MCG/ML 0 NDESMOPRESSIN ACETATE 0.1MG, 0.2MG TABS, NASAL 0.1MG/ML 0 N

P3A-THYROID HORMONESARMOUR THYROID 15MG, 30MG, 60MG, 100MG, 120MG, 180MG, 240MG, 300MG 2 NCYTOMEL 5MCG, 25MCG, 50MCG 0 NLEVOTHROID 0.0137 0 NLEVOTHYROXINE SODIUM 0.025, 0.05, 0.075, 0.88, 0.1, 0.112, 0.125MG 0 NLEVOTHYROXINE SODIUM 0.137, 0.15, 0.175, 0.2, 0.3MG 0 NTHYROID 30MG, 60MG, 120MG 0 NTHYROLAR 1/4, 1/2, 1, 2, 3 STRENGTH 2 N

P3L-ANTITHYROIDSMETHIMAZOLE 5MG, 10MG 0 NPROPYLTHIOURACIL 50MG 0 N

P4D-HYPERPARATHYROID VITAMIN D ANALOGHECTOROL 0.5MG, 1MG, 2.5MG 2 NZEMPLAR 1MCG, 2MCG, 4MCG 2 N

Effective January 1, 2013 November 1, 2013

Page 32: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 32 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

P4L-BONE RESORPTION INHIBITORS ALENDRONATE 5MG, 10MG, 35MG, 40MG, 70MG 0 NEVISTA 60MG 2 NFORTICAL 0 NMIACALCIN NASAL SOLN 200U/DOSE 0 N

P4M-CALCIMIMETIC,PARATHYROID CALCIUM ENHANCER SENSIPAR 30MG, 60MG, 90MG 2 N

P5A-GLUCOCORTICOIDSASMANEX 2 NBUDESONIDE EC 3MG 0 NCELESTONE 0.6MG/5ML SOLN 2 NCORTEF 5MG, 10MG 2 NCORTISONE ACETATE 25MG 0 NDEXAMETHASONE 0.5MG, 0.75MG, 1MG, 1.5MG, 2MG, 4MG, 6MG 0 NDEXAMETHASONE 1MG/ML, 0.5MG/5ML 0 NDEXPAK 1.5MG 2 NENTOCORT EC 3MG 2 NFLOVENT DISKUS 50MCG, 100MCG, 250MCG 2 NFLOVENT HFA SPRAY 44MCG, 110MCG, 220MCG 2 NHYDROCORTISONE 5MG, 10MG, 20MG 0 NMEDROL 2MG, 16MG 2 NMEDROL 8MG 0 NMETHYLPREDNISOLONE TABLET 4MG, 16MG, 32MG 0 NMILLIPRED 10MG/5ML 2 NMILLIPRED 5MG 2 NORAPRED ODT TAB 10MG, 15MG, 30MG 2 NPEDIAPRED LIQUID 6.7MG/5ML 2 NPREDNISOLONE ORAL SOLN 15MG/5ML, 5MG/5ML 0 NPREDNISONE 1MG, 2.5MG, 5MG, 10MG, 20MG, 50MG, 5MG/5ML, 5MG/ML 0 NPULMICORT 0.25MG/2ML, 0.5MG/2ML, 1MG/2ML (AGES 0-8) * NQVAR INH 0.04MG, 0.08MG PER ACTUATION 2 NVERIPRED 20MG/5ML 2 NZEMA-PAK 1.5MG 2 N

P5S-MINERALOCORTICOIDSFLUDROCORTISONE 0.1MG 0 N

Q2C-OPHTHALMIC ANTI-INFLAMMATORY IMMUNOMODULATOR-TYPE RESTASIS 0.05% 2 N

Q3A-RECTAL PREPSANUSOL HC 2.5% CREAM 2 NHYDROCORTISONE CREAM 2.5% 0 NPROCTOCORT 1% 2 NPROCTOCREAM HC 2.5% 2 NPROCTOSOL HC 2.5% 2 NPROCTOZONE HC 2.5% 2 N

Q3B-RECTAL/LOWER BOWEL PREP., GLUCOCORTICOID (NON-HEMORRHOID)HYDROCORTISONE ENEMA 100MG 0 N

Effective January 1, 2013 November 1, 2013

Page 33: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 33 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

Q3D-HEMORRHOIDAL PREPSHEMORRHOIDAL OINT, SUPP 0 N

Q3E-CHRONIC INFLAMMATORY COLON DX, 5-A-SALICYLAT, RECTAL TX CANASA 1000MG 2 NMESALAMINE ENEMA 4G/60ML 0 N

Q3S-LAXATIVES, LOCAL/RECTAL (may be covered for dual eligible if available over the counter)BISACODYL 10MG SUPPOSITORY 0 YDOCUSOL MINI ENEMA 2 YENEMEEZ MINI ENEMA 2 YENEMEEZ PLUS MINI ENEMA 2 YFLEET BISACODYL 10MG, MINERAL OIL, PEDIALAX, SODIUM PHOSPHATE ENEMA 2 YMINERAL OIL ENEMA 0 YSODIUM PHOSPHATE ENEMA 0 Y

Q4F-VAGINAL ANTIFUNGALSCLOTRIMAZOLE VAG CREAM, SUPPS 0 NGYNAZOLE-1 2 NGYNE-LOTRIMIN 3 DAY 2% CRM 2 NMICONAZOLE NITRATE VAG CREAM 2% 0 NMICONAZOLE VAG SUPPS 100MG, 200MG 0 NMICONAZOLE VAGINAL COMBO PAK 200MG-2%, 1200-2% CREAM 0 NNYSTATIN 100000U VAG TABS 0 NTERAZOL 3 VAG CREAM 0.8% 2 NTERAZOL 3 VAG TABS 2 NTERAZOL 7 VAG CREAM 0.4% 2 NTERCONAZOLE VAG CREAM 0.4%, 0.8% 0 NTERCONAZOLE VAG SUPPOSITORY 80MG 0 NTICONAZOLE-1 6.5% 0 N

Q4K-VAGINAL ESTROGENS ESTRING 7.5MCG/24HR 2 N

PREMARIN VAG CREAM 0.625MG/GM 2 NQ4S-VAGINAL SULFONAMIDES

AVC 15% VAG CREAM 2 NQ4W-VAGINAL ANTIBIOTICS

CLEOCIN VAG TAB 100MG 2 NCLINDAMYCIN VAG CREAM 2% 0 NCLINDESSE 2% 2 NMETROGEL VAGINAL 0.75% 2 NMETRONIDAZOLE VAGINAL GEL 0.75% 0 N

Q5A-TOPICAL PREPS, MISC (may be covered for dual eligible if available over the counter)ALUMINUM ACETATE ASTRINGENT PAD 0 YNAIL SCRUB 2 Y

Q5B-TOPICAL ANTIBACTERIALSPHISOHEX 3% 2 NPOVIDONE-IODINE OINT, SCRUB, SOLN 0 N

Effective January 1, 2013 November 1, 2013

Page 34: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 34 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

Q5F-TOPICAL ANTIFUNGALSCLOTRIM/BETAMETH CRM, LOTION 0 NCLOTRIMAZOLE CREAM 1%, AF CREAM, SOLUTION 0 NCICLOPIROX 0.77% CREAM, SHAMPOO, SUSPENSION 0 NCICLOPIROX 8% SOLUTION 0 NECONAZOLE NITRATE 1% CREAM 0 NFUNGOID TR 2 NKETOCONAZOLE 2% CREAM 0 NKETOCONAZOLE SHAMPOO 2% 0 NLOPROX GEL 0.77% 0 NMICONAZOLE NITRATE CREAM 2% 0 NNYSTATIN CREAM, OINT, PDR 100000U/GM 0 NNYSTATIN TRIAMCINOLONE CREAM, OINT 0 NTERBINAFINE 1% CREAM 0 NTOLNAFTATE CREAM, POWDER, SOLN 1% 0 N

Q5H-TOPICAL LOCAL ANESTHETICSEMLA CREAM 2.5%/2.5% 2 NL.M.X.4 4% 2 NL.M.X.4 PLUS 4% 2 NLIDOCAINE OINT 5% 0 NLIDOCAINE-HC 0.5-3% 0 NLIDOCAINE-PRILOCAINE 2.5-2.5% 0 NLIDOCAINE 3%, CREAM 0 NMPM REGENECARE 2 N

Q5N-TOPICAL ANTINEOPLASTIC & PREMALIGNANT LESION AGENTS CARAC 0.5% 2 NFLUOROPLEX CREAM 1% 2 NFLUOROURACIL CREAM 5%, SOLUTION 2%, 5% 0 NSOLARAZE 3% 2 N

Q5P-TOPICAL ANTI-INFLAMMATORY STEROIDALAMCINONIDE 0.1% LOTION, CREAM, OINTMENT 0 NBETAMETHASONE VALERATE CREAM, OINT, LOT 0.1% 0 NDERMA-SMOOTHE/FS OIL 0.01% 2 NDESONIDE CREAM, OINT 0.05% 0 NDIFLORASONE DIACETATE CREAM, OINT 0.05% 0 NFLUOCINOLONE ACETONIDE CREAM, OINT 0.025% 0 NFLUOCINOLONE ACETONIDE CREAM, SOLN 0.01% 0 NFLUOCINOLONE BODY OIL, SCALP OIL 0.01% 0 NFLUOCINONIDE CREAM, OINT, SOLN, GEL 0.05% 0 NFLUOCINONIDE E CREAM 0.05% 0 NFLUTICASONE PROPIONATE CRM 0.05% 0 NFLUTICASONE PROPIONATE OINT 0.005% 0 NHYDROCORTISONE CREAM, OINT, 0.5%, 1%, 2.5% 0 NHYDROCORTISONE LOT 1%, 2.5% 0 N

Effective January 1, 2013 November 1, 2013

Page 35: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 35 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

HYDROCORTISONE SOLUTION 0.1% 0 NMOMETASONE FUROATE CREAM, LOTION, OINT 0.1% 0 NTRIAMCINOLONE CREAM, OINT 0.025%, 0.1%, 0.5% 0 N

Q5R-TOPICAL ANTIPARISITICSEURAX CREAM 10% 2 NNATROBA 0.9% TOPICAL SUSPENSION 0 NPERMETHRIN 1% LIQUID, 5% CREAM 0 NPIPERONYL BUTOXIDE/PYRETHRINS SHAMPOO, LOTION 0 NSKLICE 0.5% 2 N

Q5S-TOPICAL SULFONAMIDESSILVER SULFADIAZINE 1% 0 NSODIUM SULFACETAMIDE-SULFUR WASH 10-5% (W/W) 0 NSULFAMYLON 8.5% 2 N

Q5V-TOPICAL ANTIVIRALSDENAVIR CREAM 1% 2 NZOVIRAX CREAM, OINT 5% 2 N

Q5W-TOPICAL ANTIBIOTICS (may be covered for dual eligible if available over the counter)BACITRACIN TOPICAL 500U/GM 0 YBACITRACIN/POLYMYXIN OINT 500U/GM/10MU/GM 0 YBACTROBAN CREAM 2% 2 NCENTANY 2% 0 NCLINDAMYCIN TOP GEL, LOTION, SOLN 1% 0 NERYTHROMYCIN GEL, SOLN 2% 0 NERYTHROMYCIN-BENZOYL PEROXIDE GEL 3%-5% 0 NGENTAMICIN SULFATE CREAM, OINT 0.1% 0 NMUPIROCIN OINT 2% 0 NTRIPLE ANTIBIOTIC OINT 0 Y

Q5X-TOPICAL ANTIBIOTICS/ANTIINFLAMMATORY,STEROIDAL CORTISPORIN OINT 1% 2 N

Q6A-EYE PREPS MISCMURO 128 SOLN, OINT 5% 2 NSODIUM CHLORIDE SOLN, OINT 5% 0 N

Q6C-EYE VASOCONSTRICTORS RXPHENYLEPHRINE SOLN 2.5%, 10% 0 N

Q6D-EYE VASOCONSTRICTORS OTCTETRAHYDROZOLINE/ZINC 0.5-0.25% 0 N

Q6G-MIOTICS/OTHER INTRAOC. PRESSURE REDUCERS ALPHAGAN P SOLN 0.1% 2 NALPHAGAN P SOLN 0.15% 0 NAZOPT SOLN 1% 2 NBETAXOLOL HCL 0.5% 0 NBRIMONIDINE TARTRATE 0.2% 0 NCARTEOLOL HCL 1% 0 NCOMBIGAN 0.2-0.5% 2 NDORZOLAMIDE 2% 0 NDORZOLAMIDE/TIMOLOL 2%-0.5% 0 N

Effective January 1, 2013 November 1, 2013

Page 36: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 36 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

ISOPTO CARBACHOL SOLN 1.5%, 3% 2 NISOPTO CARPINE 2% 2 NLATANOPROST 0.005% 0 NLEVOBUNOLOL SOLN 0.25%, 0.5% 0 NMETIPRANOLOL 0.3% 0 NPHOSPHOLINE IODIDE SOLN 0.125% 2 NPILOCARPINE SOLN 0.5%, 1%, 2%, 3%, 4%, 6% 0 NPILOPINE HS GEL 4% 2 NTIMOLOL MALEATE SOL 0.25%, 0.5% 0 NTIMOLOL MALEATE SOLN XE 0.25%, 0.5% 0 N

Q6H-EYE LOCAL ANESTHETICSPROPARICAINE HCL SOLN 0.5% 0 NTETRACAINE HCL SOLN 0.5% 0 N

Q6I-EYE ANTIBIOTIC-CORTICOID COMBINATIONS BACITRACIN/NEOMYCIN/POLYMYXIN/HC OINT 0 NDEXAMETHASONE/NEOMYCIN/POLYMYXIN OINT, SOLN 0 NTOBRADEX SUSP 0.3%/0.1% 0 N

Q6J-MYDRIATICSAK-PENTOLATE SOLN 2% 0 NATROPINE SULFATE SOLN, OINT 1% 0 NCYCLOGYL 0.5%, 1%, 2% 2 NCYCLOMYDRIL SOLN 0.2%/1% 2 NCYCLOPENTOLATE SOLN 1% 0 NISOPTO ATROPINE SOLN 1% 0 NISOPTO HOMATROPINE SOLN 2%, 5% 2 NISOPTO HYOSCINE SOLN 0.25% 2 NTROPICAMIDE SOLN 0.5%, 1% 0 N

Q6P-EYE ANTIINFLAMMATORY AGENTSALREX SOLN 0.2% 2 NDEXAMETHASONE SOD PHOSPHATE SOLN 0.1% 0 NDICLOFENAC SODIUM 0.1% 0 NDUREZOL 0.05% 2 NFLUOROMETHOLONE SOLN 0.1% 0 NFLURBIPROFEN SODIUM 0.03% 0 NFML FORTE SOLN 0.25% 2 NFML SOP OINT 0.1% 2 NKETOROLAC 0.4%, 0.5% 0 NLOTEMAX OINT, SOLN, GEL 0.5% 2 NMAXIDEX SOLN 0.1% 2 NPRED MILD SOLN 0.12% 2 NPREDNISOLONE ACETATE SOLN 1% 0 NPREDNISOLONE SOD PHOSPHATE SOLN 0.125%, 1% 0 NVEXOL SOLN 1% 2 N

Effective January 1, 2013 November 1, 2013

Page 37: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 37 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

Q6R-EYE ANTIHISTAMINEALAWAY 0.025% 0 NBEPREVE 1.5% 2 NKETOTIFEN 0.025% 0 NOPTIVAR 0.05% 0 NPATADAY 0.2% 2 NZADITOR 0.025% 0 N

Q6S-EYE SULFONAMIDESPREDNISOLONE/SULFACETAMIDE SOLN 0.25%-10% 0 NSULFACETAMIDE SODIUM, SOLN 10% 0 N

Q6T-EYE LUBRICANTS/TEARS (may be covered for dual eligible if available over the counter)ARTIFICIAL TEARS 0.5%, 1.4%, 0.3%/0.4%, 0.5%/0.6% 0 YCARBOXYMETHYLCELLULOSE SODIUM 0.5% 0 NFRESHKOTE 2 NGENTEAL MILD 2%, MILD TO MODERATE 0.30%, SEVERE 0.30% 2 YHYPOTEARS SOLN 2 YSYSTANE, SYSTANE ULTRA 0.3%-0.4%, SYSTANE BALANCE 0.6% 2 YSYSTANE GEL 0.3%-0.4% 2 YTEARS NATURALE FORTE 2 Y

Q6U-EYE MAST CELL STABILIZERSCROMOLYN SODIUM SOLN 4% 0 N

Q6V-EYE ANTIVIRALSTRIFLURIDINE SOLN 1% 0 NVIROPTIC SOLN 1% 2 N

Q6W-EYE ANTIBIOTICSBACITRACIN OINT 500U/GM 0 NBACITRACIN/POLYMYXIN OINT 0 NCIPROFLOXACIN 0.3% DROPS 0 NERYTHROMYCIN OINT 5MG/GM 0 NGENTAMICIN SOLN 3MG/ML, OINT 3MG/GM 0 NNATACYN 5% 2 NNEOMYCIN/POLYMYXIN/BACITRACIN OINT 0 NNEOMYCIN/POLYMYXIN/GRAMICIDIN SOLN 0 NOFLOXACIN 0.3% DROPS 0 NPOLYMYXIN/TRIMETHOPRIM SOLN 0 NTOBRAMYCIN SOLN 0.3% 0 N

Q6Y-EYE PREP, MISC (may be covered for dual eligible)EYE LUBRICANT OINTMENT 0 YSYSTANE NIGHTTIME EYE OINT 3%-94% 2 Y

Q7A-NOSE PREPARATIONS, MISCELLANEOUS (RX) IPRATROPIUM BR 21MCG, 42MCG NS 0 N

Q7C-NASAL VASOCONSTRICTORS RXADRENALIN NASAL SOLUTION 2 NTYZINE 0.05%, 0.1% 2 N

Effective January 1, 2013 November 1, 2013

Page 38: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 38 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

Q7D-NASAL VASOCONSTRICTORS OTCOXYMETAZOLINE HCL 0.05% 0 NPHENYLEPHRINE HCL1% 0 N

Q7E-NASAL ANTIHISTAMINEASTELIN NASAL SPRAY 137MCG 0 NASTEPRO NASAL SPRAY 137MCG 2 NPATANASE 0.6% NASAL SPRAY 2 N

CROMOLYN SODIUM 40MG/ML 0 YQ7P-NASAL, ANTI-INFLAMMATORY STEROIDS

FLUNISOLIDE 0.025% 0 NFLUTICASONE 0.05% 0 NNASACORT AQ 0 N

Q7Q-NASAL MOISTURIZER (may be covered for dual eligible if available over the counter)RHINARIS 0.2% NASAL GEL 2 Y

Q7W-NASAL ANTIBIOTICSBACTROBAN NASAL 2% 2 N

Q7Y-NASAL OTC MISC (may be covered for dual eligible if available over the counter)SODIUM CHLORIDE (SALINE) NASAL SPRAY 0.65% 0 Y

Q8B-EAR PREPS, MISC ANTI-INFECTIVEACETIC ACID HC OTIC 2% 0 NACETIC ACID OTIC 2% 0 NACETIC ACID/ ALUMINUM ACETATE 0 N

Q8F-OTIC PREPARATIONS, ANTI-INFLAMMATORY-ANTIBIOTICS CIPRODEX 0.3-0.1% 2 N

Q8H-EAR PREPS, LOCAL ANESTHETICANTIPYRINE/BENZOCAINE 0 NBENZOCAINE 20% 0 NPHENYLEPHRINE/ANTIPY/B-CAINE 0.25-5-5% 0 N

Q8P-EAR PREPARATIONS ANTI-INFLAMMATORY DERMOTIC OIL 0.01% EAR DROP 2 NFLUOCINOLONE OIL 0.01% EAR DROP 0 N

Q8R-EAR WAX REMOVAL PREPS (may be covered for dual eligible if available over the counter)CARBAMIDE PEROXIDE 6.5% 0 Y

Q8W-EAR ANTIBIOTICSNEOMYCIN/POLYMYXIN/HC SUSP, SOLN 0 NOFLOXACIN OTIC 0 N

Q9B-BPH/MICTURITION AGENTSFINASTERIDE 5MG 0 NTAMSULOSIN 0.4MG 0 N

RIA-URINARY TRACT ANTISPASMODICS/ANTIINCONTINENCE AGENT FLAVOXATE 100MG 0 NOXYBUTYNIN CHLORIDE 5MG 0 NOXYBUTYNIN CHLORIDE 5MG/5ML 0 N

Q7H-NASAL MAST CELL STABILIZERS AGENTS (may be covered for dual eligible if available over the counter)

Effective January 1, 2013 November 1, 2013

Page 39: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 39 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

OXYBUTYNIN ER 5MG, 10MG, 15MG 0 NSANCTURA 20MG 0 NSANCTURA XR 60MG 0 N

R1E-CARBONIC ANHYDRASE INHIBITORSACETAZOLAMIDE 125MG, 250MG 0 NDIAMOX SEQUELS 500MG 0 NMETHAZOLAMIDE 25MG, 50MG 0 N

R1F-THIAZIDE DIURETIC & RELCHLOROTHIAZIDE 250MG, 500MG 0 NCHLORTHALIDONE 25MG, 50MG 0 NDIURIL 250MG/5ML 2 NHYDROCHLOROTHIAZIDE 12.5MG, 25MG, 50MG 0 NINDAPAMIDE 1.25MG, 2.5MG 0 NMETHYCLOTHIAZIDE 5MG 0 NMETOLAZONE 2.5MG, 5MG, 10MG 0 N

R1H-POTASSIUM SPARING DIURETICS (SEE ALSO P5T) AMILORIDE HCL 5MG 0 N

EPLERENONE 25MG, 50MG 0 NSPIRONOLACTONE 25MG, 50MG, 100MG 0 N

R1L-POTASSIUM SPARING DIURETICS IN COMBINATION AMILORIDE/HCTZ 5/50 0 NSPIRONOLACTONE/HCTZ 25/25 0 NTRIAMTERENE HCTZ 25/50, 25/37.5, 50/75 0 N

R1M-LOOP DIURETICS BUMETANIDE 0.5MG, 1MG, 2MG 0 NEDECRIN 25MG 2 NFUROSEMIDE 10MG/ML ORAL, 40MG/5ML ORAL 0 NFUROSEMIDE 20MG, 40MG, 80MG 0 NTORSEMIDE 5MG, 10MG, 20MG, 100MG 0 N

R1N-ARGININE VASOPRESSIN (AVP) RECEPTOR ANTAGONISTS SAMSCA 15MG, 30MG 2 N

R1R-URICOSURIC AGENTSPROBENECID 500MG 0 N

R1S-URINARY PH MODIFIERSCITRIC ACID/SODIUM CITRATE 334-500MG 0 NCYTRA-2 SOLN 0 NCYTRA-3 SOLN 0 NCYTRA-K SOLN, CRYSTALS PACKET 0 NK-PHOS M.F., #2 2 NK-PHOS NEUTRAL 250MG 2 NK-PHOS ORIGINAL 2 NPHOSPHA 250 NEUTRAL 250 MG 2 NPOTASSIUM CITRATE 5 MEQ, 10 MEQ 0 NPOTASSIUM CITRATE/CITRIC ACID 0 N

Effective January 1, 2013 November 1, 2013

Page 40: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 40 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

RENACIDIN SOLN 0 NUROCIT-K 5MEQ, 10MEQ, 15MEQ 2 NUROQID-ACID NO.2 2 N

R4A-KIDNEY STONE AGENTSCYSTAGON 50MG, 150MG 2 NTHIOLA 2 N

R5A-URINARY TRACT ANESTHETIC/ANALGESIC AGENTSAZO 95MG 2 NPHENAZOPYRIDINE 100MG, 200MG 0 NPHENAZOPYRIDINE PLUS 150-0.3-15 0 N

R5B-URINARY ANALGESICSELMIRON 100MG 2 N

S2A-COLCHICINESPROBENECID W/ COLCHICINE 500MG/0.5MG 0 N

S2B-NSAIDS, CYCLOOXYGENASE INHIBITOR - TYPE ADVIL 40MG/ML, 100MG/5ML 0 NCELEBREX 50MG, 100MG, 200MG, 400MG (AGE 60+) 2 NDICLOFENAC POTASSIUM 50MG 0 NDICLOFENAC SODIUM 25MG, 50MG, 75MG, 100MG 0 NETODOLAC 200MG, 300MG, 400MG, 500MG 0 NETODOLAC XL 400MG, 500MG, 600MG 0 NFENOPROFEN CALCIUM 600MG 0 NFLURBIPROFEN 50MG, 100MG 0 NIBUPROFEN 100MG, 200MG, 400MG, 600MG, 800MG 0 NIBUPROFEN 100MG/5ML SUSP, 40MG/ML DROPS 0 NINDOCIN SUPP 50MG 2 NINDOCIN SUSP 25MG/5ML 2 NINDOMETHACIN 25MG, 50MG 0 NKETOPROFEN 200MG SR 0 NKETOPROFEN 50MG, 75MG 0 NKETOROLAC TROMETHAMINE 10MG 0 NMECLOFENAMATE SODIUM 50MG, 100MG 0 NMELOXICAM 7.5MG, 15MG 0 NMOTRIN 40MG/ML, 100MG/5ML 0 NNABUMETONE 500MG, 750MG 0 NNAPROSYN 125MG/5ML 2 NNAPROXEN 250MG, 375MG, 500MG, 125MG/5ML 0 NNAPROXEN EC 375MG, 500MG 0 NNAPROXEN SODIUM 220MG, 275MG, 550MG 0 NOXAPROZIN 600MG 0 NPIROXICAM 10MG, 20MG 0 NSULINDAC 150MG, 200MG 0 N

S2C-GOLD SALTSRIDAURA 3MG 2 N

S2I-ANTI-INFLAMMATORY, PYRIMIDINE SYNTHESIS INHIBITOR LEFLUNOMIDE 10MG, 20MG 0 N

Effective January 1, 2013 November 1, 2013

Page 41: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 41 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

S2K-ANTI-ARTHRITIC AND CHELATING AGENTS CUPRIMINE 250MG 2 NDEPEN 250MG 2 N

S2M-ANTI-INFLAM. INTERLEUKIN-1 RECEPTOR ANTAGONIST ARCALYST 220 MG INJECTION 2 N

T0C-TOPICAL GENITAL WART-HPV TREATMENT AGENTS VEREGEN 15% OINTMENT 2 N

U6E-OINTMENT-CREAM BASESHYDROPHILIC PETROLATUM 2 N

U6F-HYDROPHILIC CREAM/OINTMENT BASESHYDROPHILIC 2 NTRIAD 2 N

U6N-VEHICLESORA-BLEND 2 NORA-BLEND SF 2 NORA-PLUS 2 NORA-SWEET 2 NORA-SWEET SF 2 NSORBITOL 70% 0 N

U6W-BULK CHEMICALSARGININE-L POWDER 0 NCLORPACTIN WCS-90 2 NHYDROUS EMULSIFIED BASE 0 NL-CITRULLINE POWDER 0 NL-GLUTAMINE PDR 2 NL-ISOLEUCINE POWDER 0 NSODIUM BENZOATE POWDER 0 NZINC SULFATE PDR 2 N

V1A-ALKYLATING AGENTSALKERAN 2MG 2 NCEENU 10MG, 40MG, 100MG 2 NCYCLOPHOSPHAMIDE 25MG, 50MG TAB 0 NDROXIA 200MG, 300MG, 400MG 2 NHEXALEN 50MG 2 NHYDROXYUREA 500MG 0 NLEUKERAN 2MG 2 NMYLERAN 2MG 2 NTEMODAR 5MG, 20MG, 100MG, 140MG, 180MG, 250MG 2 N

V1B-ANTIMETABOLITESMERCAPTOPURINE 50MG 0 NMETHOTREXATE TAB 2.5MG 0 NOFORTA 10MG 2 NPURINETHOL 50MG 2 NTABLOID 40MG 2 NTHIOGUANINE 40MG 2 NXELODA 150MG, 500MG 2 N

Effective January 1, 2013 November 1, 2013

Page 42: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 42 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

V1E-STEROID ANTINEOPLASTICSEMCYT 140MG 2 NMEGESTROL ACETATE 20MG, 40MG, 40MG/ML 0 N

V1F-MISC ANTINEOPLASTICSETOPOSIDE 50MG 0 NLYSODREN 500MG 2 NMATULANE 50MG 2 NTRETINOIN 10MG 0 N

V1I-CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS LEUCOVORIN CALCIUM TABS 5MG, 25MG 0 N

V1J-ANTIANDROGENIC AGENTS BICALUTAMIDE 50MG 0 NFLUTAMIDE 125MG 0 NNILANDRON 150MG 2 N

V1M-ANTINEOPLASTIC IMMUNOMODULATOR AGENTS SYLATRON 296MCG 2 N

V1Q-ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS CAPRELSA 300MG 2 NCOMETRIQ 60, 100, 140MG DAILY DOSE 2 NGLEEVEC 100MG, 400MG 2 NINLYTA 1MG, 5MG 2 NIRESSA 250MG 2 NMEKINIST 0.5, 2 MG 2 NNEXAVAR 200MG 2 NSUTENT 12.5MG, 25MG, 50MG 2 NTAFINLAR 50, 75 MG 2 NTARCEVA 25MG, 100MG, 150MG 2 NTASIGNA 150MG, 200MG 2 NTYKERB 250MG 2 NVANDETANIB 100MG 2 NVOTRIENT 200MG 2 NXALKORI 250MG 2 NZELBORAF 240MG 2 N

V1T-SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERM) FARESTON 60MG 2 NTAMOXIFEN CITRATE 10MG, 20MG 0 N

V3C-ANTINEOPLASTIC - MTOR KINASE INHIBITORS AFINITOR 2.5MG, 5MG, 7.5MG, 10MG 2 NAFINITOR DISPERZ 2MG, 3MG, 5MG 2 N

V3E-ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS HYCAMTIN 0.25MG, 1MG 2 N

V3F-ANTINEOPLASTIC - AROMATASE INHIBITORS ANASTROZOLE 1MG 0 NEXEMESTANE 25MG 0 NFEMARA 2.5MG 2 NLETROZOLE 2.5MG 0 N

Effective January 1, 2013 November 1, 2013

Page 43: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 43 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

V3L-ANTINEOPLASTIC - JANUS KINASE (JAK) INHIBITORS JAKAFI 5MG, 10MG, 15MG, 20MG, 25MG 2 N

V3M-ANTINEOPLASTIC - HEDGEHOG PATHWAY INHIBITOR ERIVEDGE 150MG 2 N

W1A-PENICILLINSAMOX TR/POTASSIUM CLAV 200-28.5/5, 250-62.5/5, 400-57/5, 600-42.9/5ML 0 NAMOX TR/POTASSIUM CLAV 250-125MG, 500-125MG, 875-125MG, 1000-62.5 0 NAMOX TR/POTASSIUM CLAV CHEW TAB 200-28.5, 400-57 0 NAMOXICILLIN 250MG, 500MG, 875MG, 125MG/5ML, 250MG/5ML 0 NAMOXICILLIN 200MG/5ML, 400MG/5ML 0 NAMOXICILLIN CHEWABLE 125MG, 200MG, 250MG, 400MG 0 NAMPICILLIN 250MG, 500MG 0 NAMPICILLIN SUSP 125MG/5ML, 250MG/5ML 0 NAUGMENTIN CHEWABLES 250/62.5 0 NAUGMENTIN SUSP 125-31.25/5ML 0 NAUGMENTIN SUSP 250-62.5/5ML 0 NAUGMENTIN XR 1000-62.5 2 NDICLOXACILLIN 250MG, 500MG 0 NPENICILLIN VK 250MG, 500MG, 125MG/5ML, 250MG/5ML 0 N

W1C-TETRACYCLINESDOXYCYCLINE HYCLATE 50MG, 100MG 0 NMINOCYCLINE HCL 50MG, 75MG, 100MG 0 NTETRACYCLINE HCL 250MG, 500MG 0 NVIBRAMYCIN 25MG/5ML SUSP 2 NVIBRAMYCIN CALCIUM 50MG/5ML SYRUP 2 N

W1D-MACROLIDESAZITHROMYCIN 250MG, 500MG, 600MG 0 NAZITHROMYCIN PACKETS 1GM 0 NAZITHROMYCIN SUSP 100MG/5ML, 200MG/5ML 0 NCLARITHROMYCIN 250MG, 500MG 0 NCLARITHROMYCIN ER 500MG 0 NCLARITHROMYCIN SUSP 125MG/5ML, 250MG/5ML 0 NDIFICID 200MG 2 NERYTHROMYCIN 250MG 0 NERYTHROMYCIN 333MG 0 NERYTHROMYCIN 500MG 0 NERYTHROMYCIN ETHYLSUCCINATE 400MG, 200MG/5ML, 400MG/5ML 0 NERYTHROMYCIN STEARATE 250MG, 500MG 0 NERYTHROMYCIN W/ SULFISOXAZOLE 200/600 SUSP 0 N

W1F-AMINOGLYCOSIDESNEO-FRADIN 125MG/5ML 2 NNEOMYCIN SULFATE 500MG 0 NTOBI 300MG/5ML, PODHALER 28MG 2 N

Effective January 1, 2013 November 1, 2013

Page 44: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 44 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

W1G-ANTITUBERCULAR ANTIBIOTICSRIFAMPIN 150MG, 300MG 0 NRIFATER 120/50/300 2 NSEROMYCIN 250MG 2 N

W1J-VANCOMYCIN AND DERIVATIVES VANCOCIN 125MG, 250MG 2 NVANCOMYCIN 125MG, 250MG 0 N

W1K-LINCOSAMIDESCLEOCIN 75MG, 75MG/5ML 2 NCLINDAMYCIN HCL 150MG, 300MG, 75MG/5ML 0 N

W1N-POLYMYXIN AND DERIVATIVESCOLISTIMETHATE NA 150MG 0 NCOLY-MYCIN M INJ 150MG 2 N

W1P-BETALACTAMSCAYSTON 75 MG/ML 2 N

W1Q-QUINOLONESCIPRO SUSP (AGES 0-12) * NCIPROFLOXACIN 250MG, 500MG, 750MG 0 NLEVOFLOXACIN 250MG, 500MG, 750MG, 250MG/10ML 0 NOFLOXACIN 200MG, 300MG, 400MG 0 N

W1W-CEPHALOSPORINS - 1ST GENERATION CEFADROXIL MONOHYDRATE 500MG, 1G, 250MG/5ML, 500MG/5ML 0 NCEPHALEXIN 250MG, 500MG, 125MG/5ML, 250MG/5ML 0 N

W1X-CEPHALOSPORINS - 2ND GENERATION CEFACLOR 250MG, 500MG 0 NCEFACLOR ER 500MG 0 NCEFACLOR SUSP 125/5, 250/5, 375/5ML (AGE 0 THROUGH 12) 0 NCEFPROZIL 250MG, 500MG 0 NCEFTIN SUSPENSION (AGE 0 THROUGH 12) * NCEFUROXIME 250MG, 500MG 0 NCEFUROXIME SUSPENSION (AGE 0 THROUGH 12) * N

W1Y-CEPHALOSPORINS - 3RD GENERATION CEFDINIR 300MG, 125MG/5ML, 250MG/5ML 0 N

W2A-ABSORBABLE SULFONAMIDESSULFADIAZINE 500MG 0 NSULFAMETHOXAZOLE/TRIMETHOPRIM SUSP 200-40/5 0 NSULFAMETHOXAZOLE/TRIMETHOPRIM TAB 400/80, 800/160 0 NSULFASALAZINE 500MG, EC500MG 0 N

W2E-ANTI-MYCOBACTERIUM AGENTSETHAMBUTOL HCL 100MG, 400MG 0 NISONIAZID 100MG, 300MG, 50MG/5ML 0 NMYAMBUTOL 100MG, 400MG 2 NMYCOBUTIN 150MG 2 NPASER 4GM 2 NPYRAZINAMIDE 500MG 0 NTRECATOR-SC 250MG 2 N

Effective January 1, 2013 November 1, 2013

Page 45: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 45 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

W2F-NITROFURAN DERIVATIVESFURADANTIN 25MG/5ML ORAL SUSP (AGES 0-12) * NMACRODANTIN 25MG, 50MG, 100MG 2 NNITROFURANTOIN MACROCRYSTAL 50MG, 100MG 0 NNITROFURANTOIN MONOHYDRATE MACRO 100MG 0 N

W2G-CHEMOTHERAPEUTICS, ANTIBACTERIAL, MISC. HIPREX 1GM 2 NMETHENAMINE HIPPURATE 1GM 0 NMETHENAMINE MANDELATE 500MG, 1GM 0 NMONUROL 3GM 2 NMTH/ME BLUE/SALICY/NA PHOS/HYO 81.6-0.12MG 81.6-10.8MG, 120-0.12MG 0 NPRIMSOL 50MG/5ML 2 NPROSED DS 2 NTRIMETHOPRIM 100MG 0 NUREX 1GM 2 NUTA 120-0.12MG 2 NUTIRA-C 81.6-10.8MG 2 N

W3A-ANTIFUNGAL ANTIBIOTICSGRIFULVIN V 500MG 2 NGRISEOFULVIN 125MG/5ML 0 NGRIS-PEG 125MG, 250MG 2 NNYSTATIN SUSP 100000U/ML, TAB 500,000U 0 N

W3B-ANTIFUNGALSANCOBON 250MG, 500MG 2 NCLOTRIMAZOLE TROCHE 10MG 0 NFLUCONAZOLE 50MG, 100MG, 150MG, 200MG, 50MG/5ML, 200MG/5ML 0 NKETOCONAZOLE 200MG 0 NTERBINAFINE HCL 250MG TABLET 0 N

W4A-ANTIMALARIALSCHLOROQUINE PHOSPHATE 250MG, 500MG 0 NCOARTEM 20MG-120MG 2 NDARAPRIM 25MG 2 NHYDROXYCHLOROQUINE SULFATE 200MG 0 NMALARONE 62.5/25MG, 250/100MG 2 NMEFLOQUINE 250MG 0 NPRIMAQUINE PHOSPHATE 26.3MG 2 NQUALAQUIN 324MG 2 N

W4C-AMEBACIDESPAROMOMYCIN 250 MG 0 N

W4E-ANAEROBIC ANTIPROTOZOAL-ANTIBACTERIAL AGENTS FLAGYL ER 750MG 2 NMETRONIDAZOLE 250MG, 500MG 0 N

W4G-2ND GEN. ANAEROBIC ANTIPROTOZOAL-ANTIBACTERIAL TINDAMAX 250MG, 500MG 2 N

Effective January 1, 2013 November 1, 2013

Page 46: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 46 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

W4K-MISC ANTI-PROTOZOALSMEPRON 750MG/5ML 2 NNEBUPENT AEROSOL 2 N

W4L-ANTHELMINTICSALBENZA 200MG 2 NBILTRICIDE 600MG 2 NMEBENDAZOLE 100MG 0 NSTROMECTOL 3MG 2 N

W4M-ANTIPARASITICS ALINIA 100MG/5ML 2 NALINIA 500MG 2 N

W4P-ANTI-LEPROTICSDAPSONE 25MG, 100MG 2 N

W5A-ANTIVIRALS, GENERALACYCLOVIR 200MG, 400MG, 800MG, 200MG/5ML 0 NGANCICLOVIR 250MG, 500MG 0 NRELENZA 5MG 2 NRIMANTADINE 100MG 0 NTAMIFLU 6MG/ML, 12MG/ML 2 NTAMIFLU 30MG, 45MG, 75MG 2 NVALACYCLOVIR 500MG, 1000MG 0 NVALCYTE 450MG, 50MG/ML 2 NVALTREX 500MG, 1000MG 2 N

W5C-ANTIVIRALS, HIV-SPECIFIC, PROTEASE INHIBITORSCRIXIVAN 100MG, 200MG, 400MG 2 NINVIRASE 200MG, 500MG 2 NLEXIVA 700MG TABLET, 50MG/ML SUSPENSION 2 NNORVIR 100MG, 80MG/ML SOLN 2 NREYATAZ 100MG, 150MG, 200MG, 300MG 2 NVIRACEPT 250MG, 625MG, PED ORAL PDR 50MG/GM 2 N

W5F-HEPATITIS B TREATMENT AGENTS BARACLUDE 0.05MG/ML 2 NBARACLUDE 0.5MG, 1MG 2 NEPIVIR HBV 100MG, 25MG/5ML 2 NHEPSERA 10MG 2 NTYZEKA 600MG 2 N

W5G-HEPATITIS C TREATMENTSINFERGEN 9MCG/0.3ML, 15MCG/0.5ML 2 NPEGASYS 180MCG/ML 2 NPEGASYS PROCLICK 135MCG/0.5ML, 180MCG/0.5ML 2 NPEGASYS SYRINGE 180MCG/0.5ML 2 NPEG-INTRON 100MCG, 160MCG, 240MCG 2 NPEG-INTRON REDIPEN 120MCG/0.5, 150MCG/0.5 2 NPEG-INTRON REDIPEN 50MCG/0.5, 80MCG/0.5 2 NREBETOL 40MG/ML 2 NRIBAVIRIN 200MG TAB, CAP 0 N

Effective January 1, 2013 November 1, 2013

Page 47: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 47 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

W5I-ANTIVIRALS, HIV-SPECIFIC, NUCLEOTIDE ANALOG, RTI VIREAD 150MG, 200MG, 250MG, 300MG, 40MG/GRAM 2 N

W5J-ANTIVIRALS, HIV-SPECIFIC, NUCLEOSIDE ANALOG, RTI ABACAVIR 300MG 0 NDIDANOSINE 125MG, 200MG, 250MG, 400MG 0 NEMTRIVA 200MG 2 NEPIVIR 150MG, 300MG, 10MG/ML ORAL SOLN 2 NLAMIVUDINE 150MG, 300MG 0 NRETROVIR 100MG, 10MG/ML SYRUP 2 NSTAVUDINE 15MG, 20MG, 30MG, 40MG, 1MG/ML 0 NVIDEX EC 125MG, 200MG, 250MG, 400MG 2 NVIDEX PED SUSP 2GM/120MG, 4GM/240ML 10MG/ML 2 NZERIT 1MG/ML ORAL 2 NZIAGEN 20MG/ML 2 NZIAGEN 300MG 2 NZIDOVUDINE 100MG, 300MG, 10MG/ML 0 N

W5K-ANTIVIRALS, HIV-SPECIFIC, NON-NUCLEOSIDE, RTI INTELENCE 100MG, 200MG 2 NNEVIRAPINE 200MG, 50MG/5ML 0 NRESCRIPTOR 100MG, 200MG 2 NSUSTIVA 50MG, 200MG, 600MG 2 NVIRAMUNE 200MG, 50ML/5ML 2 NVIRAMUNE XR 100MG, 400MG 2 N

W5L-ANTIVIRALS, HIV-SPEC., NUCLEOSIDE ANALOG, RTI COMBO COMBIVIR 150MG/300MG 2 0 NEPZICOM 600-300MG 2 NTRIZIVIR 300-150MG 2 N

W5M-ANTIVIRALS, HIV-SPECIFIC, PROTEASE INHIBITOR COMBOKALETRA 25-100, 50-200 2 NKALETRA 400-100/5ML 2 N

W5N-ANTIVIRALS, HIV-SPECIFIC, FUSION INHIBITORSFUZEON 90MG/ML 2 N

W5O-ANTIVIRALS, HIV-SPEC, NUCLEOSIDE-NUCLEOTIDE ANALOG TRUVADA 200MG-300MG 2 N

W5P-ANTIVIRALS, HIV-SPEC, NON-PEPTIDIC PROTEASE INHIBAPTIVUS 250MG, 100MG/ML 2 NPREZISTA 75MG, 150MG, 400MG, 600MG, 100MG/ML 2 N

W5Q-ANTIRETROVIRAL COMB NUCLEOSIDE, NUCLEOTIDE, & NON-NUCLEOSIDE RTI ATRIPLA 600-200 2 NCOMPLERA 200-25-300MG 2 N

W5T-ANTIVIRALS, HIV-SPECIFIC, CCR5 CO-RECEPTOR ANTAGONITSTSSELZENTRY TABLET 150MG, 300MG 2 N

W5U-ANTIVIRALS, HIV-1 INTEGRASE STRAND TRANSFER INHIBITOR ISENTRESS 400MG 2 N

W5X-ARV CMB-NRTI,N(T)RTI, INTEGRASE INHIBITORSTRIBILD 150/150/200/300 2 N

Effective January 1, 2013 November 1, 2013

Page 48: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 48 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

W7C-INFLUENZA VIRUS VACCINES (COVERED DURING INFLUENZA SEASON)AFLURIA 0 NFLUARIX 0 NFLULAVAL 0 NFLUMIST NASAL 0 NFLUVIRIN 0 NFLUZONE 0 N

W8F-IRRIGANTSACETIC ACID SOLN 0.25% 0 NLACTATED RINGERS IRRIGATION 0 NNEOSPORIN G.U. IRRIGANT 2 NSEA-CLENS 2 NSODIUM CHLORIDE SOLN 0.45%,0.9% 0 NSORBITOL UROLOGIC IRRIGATION 3%, 3.3% 0 NWATER FOR IRRIGATION, STERILE 0 N

W8J-MISC ANTIBACTERIAL IRRIGANTSAMINOACETIC ACID IRRIGATION 1.5% 0 NGLYCINE 0 N

W9A-KETOLIDESKETEK 300MG, 400MG 2 N

ZIE-ANTIOXIDANT AGENTS (MAY BE COVERED FOR DUAL ELIGIBLE)ALPHA LIPOIC ACID 100MG, 300MG 0 Y

Z2D-HISTAMINE 2 INHIBITORSCIMETIDINE 200MG, 300MG, 400MG, 800MG, 300MG/5ML 0 NFAMOTIDINE 10MG 0 NFAMOTIDINE 20MG, 40MG 0 NRANITIDINE 150MG, 300MG 0 NRANITIDINE 150MG/10ML SYRUP, 15MG/ML ORAL SOLN (0-12 YRS) * N

Z2E-IMMUNOSUPPRESSIVESAZASAN 75MG, 100MG 2 NAZATHIOPRINE 50MG 0 NCELLCEPT 200MG/ML 2 NCYCLOSPORINE 25MG, 50MG, 100MG, 100MG/ML 0 NGENGRAF 25MG, 100MG, 100MG/ML 2 NMYCOPHENOLATE MOFETIL 250MG, 500MG 0 NMYFORTIC 180MG, 360MG 2 NNEORAL 100MG/ML ORAL 2 NNEORAL 25MG, 100MG 2 NPROGRAF 0.5MG, 1MG, 5MG 2 NRAPAMUNE 0.5MG, 1MG, 2MG 2 NRAPAMUNE 1MG/ML 2 NSANDIMMUNE 100MG/ML SOLUTION 2 NSANDIMMUNE 25MG, 100MG 2 NZORTRESS 0.25MG, 0.5MG, 0.75MG 2 N

Effective January 1, 2013 November 1, 2013

Page 49: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 49 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

Z2F-MAST CELL STABILIZERS CROMOLYN SODIUM 10MG/ML INH SOLN 0 NGASTROCOM 20MG/ML 2 N

Z2G-IMMUNOMODULATORSINTRON A 6MMU, 10MMU, 18MMU, 50MMU 2 NINTRON A PEN DELIVERY SYSTEMS 3MMU, 5MMU, 10MMU 2 N

Z2N-1ST GEN ANTIHISTAMINE & DECONGESTANT COMBINATIONS CHILD DELSYM COUGH-COLD 5-12.5/5ML 2 NPHENYLEPHRINE/BROMPHENIRAMINE 2.5-1MG/5 0 NPHENYLEPHRINE/CHLORPHENIRAMINE 3.5-1MG/ML, 2MG-1MG/ML, 9-0.8MG/ML 0 NPHENYLEPHRINE/CHLORPHENIRAMINE MAL 10MG-3MG, 10MG-4MG, 20MG-8MG, 5MG-2MG/ML 0 NPHENYLEPHRINE/CHLORPHENIRAMINE TAN 60-2/1MG 0 NPHENYLEPHRINE/DIPHENHYDRAMINE 2.5-6.25MG/5ML 0 NPROMETHAZINE VC SYRUP 0 NPSEUDOEPHEDRINE/BROMPHENIRAMINE 7.5-1/1ML, 15-1/5ML 0 NPSEUDOEPHENDRIN/CHLORPHENIRAMINE SYRUP 2MG-30MG/5ML 0 NPSEUDOEPHEDRINE HCL/CHLOR-MAL 60MG-4MG, 90-0.8MG/ML, 120MG-8MG 0 NPSEUDOEPHEDRINE/TRIPROLIDINE LIQUID 60-2.5, 30-1.25/5ML 0 NSONAHIST 2MG-1MG/ML 2 N

Z2O-2ND GEN ANTIHISTAMINE & DECONGESTANT COMBINATIONS ALLERGY RELIEF D 240-10MG 0 NCETIRIZINE/PSEUDOEPHRINE 5/120MG 0 NLORATADINE D 240-10MG 0 NSEMPREX-D 60/8 2 N

Z2P-ANTIHISTAMINES - 1ST GENERATION (oral diphenhydramine may be available for dual eligible)BROMPHENIRAMINE 6MG 0 NCARBINOXAMINE SYRUP 4MG/5ML 0 NCHLORPHENIRAMINE 4MG, 12MG 0 NCHLORPHENIRAMINE 2MG/5ML, 2MG/ML 0 NCLEMASTINE 1.34MG, 2.68MG, 0.67MG/5ML 0 NCYPROHEPTADINE 4MG 0 NCYPROHEPTADINE SYRUP 2MG/5ML 0 NDEXCHLORPHENIRAMINE MALEATE 2MG/5ML 0 NDIPHENHYDRAMINE 25MG, 50MG, 12.5MG/5ML 0 YHYDROXYZINE HCL 10MG, 25MG, 50MG 0 NHYDROXYZINE HCL SYRUP 10MG/5ML 0 NHYDROXYZINE PAMOATE 25MG, 50MG, 100MG 0 NPALGIC 4MG, 4MG/5ML 2 NPROMETHAZINE HCL 12.5MG, 25MG, 50MG TAB 0 NPROMETHAZINE SYRUP 6.25MG/5ML 0 NVANAHIST PD 0.625 MG/ML 2 N

Z2Q-ANTIHISTAMINES - 2ND GENERATION ALLERGY RELIEF 5MG/5ML (LORATADINE) 0 NCETIRIZINE HCL CHEWABLE TABS 5MG, 10MG (AGES 0-6) * N

Effective January 1, 2013 November 1, 2013

Page 50: ACTION: Original AMENDED DATE: 08/07/2013 1:34 …3-9-12...2012/03/09  · B3P-NON-NARC ANTITUS-1ST GEN ANTIHIST-DECON-ANALGES CB (cough suppressants may be covered for dual eligible)

5101:3-9-12 Appendix

AMEND

Page 50 of 50D

RU

G C

LASS

DRUG NAME CO

-PA

YMEN

T

CO

VER

ED

FOR

DU

AL

ELIG

IBLE

CETIRIZINE HCL 5MG, 10MG 0 NCETIRIZINE HCL 1MG/1ML (AGES 0-6) * NLORATADINE 10MG, 10MG RAPID DISSOLVE, 5MG/5ML 0 N

Z4B-LEUKOTRIENE RECEPTOR ANTAGONISTS ACCOLATE 10MG, 20MG 2 NMONTELUKAST 4MG, 5MG, 10MG 0 NSINGULAIR ORAL GRANULES 4MG 0 NZAFIRLUKAST 10MG, 20MG 0 N

Effective January 1, 2013 November 1, 2013